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Highlighting Minnesota
What This Report Is and How It Can Be Used
For patients whose conditions can be treated with elective surgery, location matters. 
In this Dartmouth Atlas report, the first in a series looking at individual states and 
regions, we show the wide regional variation in the likelihood that patients with similar 
conditions receive elective procedures. This report highlights Minnesota and shows 
the variation across the state. For example, if you have heart disease and live in St. 
Cloud, Minnesota, you are half as likely to undergo cardiac bypass surgery than if 
you live in Detroit Lakes, and more than twice as likely to undergo back surgery than 
if you live in Rochester. If you have gallstones and live in Wadena, you are three 
times more likely to have your gall bladder removed than if you live in Minneapolis.
Variations of a similar magnitude were found across the state for other procedures 
as well. Among the largest 60 communities in Minnesota, we found fourfold variation 
in coronary angioplasty and stenting and more than threefold variation in carotid 
endarterectomy, a procedure performed to prevent stroke. The greatest variation 
was seen in transurethral resection of the prostate, or TURP, a procedure for treat-
ing benign prostate hyperplasia. Among the 60 largest communities, rates of TURP 
varied an astonishing sevenfold, ranging from a low of 1.6 per 1,000 male Medicare 
beneficiaries in Rochester to 11.6 per 1,000 in Bemidji.
In highlighting the variation from community to community for these and other elec-
tive procedures, we hope to help patients, families and clinicians—physicians, 
nurses and other health care providers—better understand both the importance of 
these variations and their major cause: the fact that patients’ preferences are not 
always taken into account when medical decisions are made. This report is intended 
to encourage patients and their families to make sure they are fully informed about 
their choices and to share important health care decisions with their clinicians.
All too often, patients facing the possibility of elective surgery are not given an 
opportunity to understand their options fully. Many patients are not even aware that 
the decision about elective surgery is actually a choice and that it should generally 
be theirs to make. Instead, they routinely delegate such important, even life-altering 
decisions to their clinicians in the belief that “the doctor knows best.” The result is 
that patients often do not get the treatment that they would prefer. Research sug-
gests that for many conditions—especially those that can be treated with elective 
surgery—the treatment a patient receives depends more on the physician’s recom-
mendations than the patient’s preferences.1
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Clinicians are not mind readers. They often do not know or ask their patients about 
their values and preferences; or they may assume that the patient’s values are simi-
lar to their own. As a result, they may recommend treatment that is different from 
what their patients would have chosen had they been fully informed.2,3 Clinicians 
also vary widely in their opinions about the best course of treatment for any given 
condition.
These differences in clinicians’ personal beliefs and opinions contribute to the 
variation in surgical rates in different geographic locations. For example, there is 
considerable disagreement among surgeons about the need for back surgery, its 
effectiveness, and even the best way to diagnose the cause of back pain. With no 
consensus about how to diagnose and treat back pain, the rate of back surgery var-
ies widely from place to place.
This report, a collaborative project with the Foundation for Informed Medical Deci-
sion Making, looks at the variation in surgical rates in 306 hospital referral regions 
across the United States (a hospital referral region is a large health care market con-
taining at least one referral hospital). In the Appendix, patients can find the rates for 
ten different surgical procedures and one test in 121 different hospital service areas 
in Minnesota (a hospital service area encompasses the geographic area served by 
a relatively small number of hospitals). Future editions will look at variation in the 
rates of these procedures in other states and regions. Data for the entire nation, 
encompassing more than 3,400 hospital service areas, can be found on the Dart-
mouth Atlas web site (www.dartmouthatlas.org).
This report is divided into three parts. The first section, “The Importance of Choice in 
Health Care,” explains the concept of shared decision-making, a process that helps 
patients understand their choices fully and allows them to share treatment decisions 
with their clinicians. The second section, “Variation in Preference-Sensitive Care,” 
briefly describes the treatment choices facing patients with eight different conditions, 
all of which can—but do not have to be—treated with surgery.
The last section, “Ensuring Patients Get the Care They Need and Want,” discusses 
steps patients can take to make sure they get the care they want and need. It also 
discusses how physicians and other clinicians can support shared decision-making 
to ensure that patients make fully informed choices. When done right, shared deci-
sion-making results in a better decision: a personalized choice based on the best 
scientific evidence and the patient’s own values.
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The Importance of Choice in Health Care
Medicine involves decisions. Traditionally, patients have relied on their clinicians—
physicians, nurses and other health care providers—to decide for them: to prescribe 
tests, surgeries and drugs; to refer them to specialists; and to admit them to hospitals 
and intensive care units. But some of the most important choices in medicine are 
not the clinician’s alone to make. These decisions should be shared with patients.
The patient’s preference for the kind of care he or she wants is especially important 
when facing a test, surgery or other treatment that is “elective.” When a treatment 
is elective, it means there is more than one way to treat the patient’s illness or 
condition, each possible treatment involves different trade-offs, and individual 
patients will view those trade-offs differently. Sometimes, doing nothing at first—
“watchful waiting”—may be a completely reasonable option.
In order to ensure that each patient gets the treatment that is right for him or her, 
the choice should be a shared decision, involving both the patient and the clinician. 
In the process known as “shared decision-making,” the patient is a fully informed 
partner in the choice, knowledgeable about the risk and benefit trade-offs of each 
treatment option. When done right, shared decision-making results in a better 
decision: a personalized choice based on both the best scientific evidence and the 
patient’s own values.
For example, consider the importance of shared decision-making to women who 
have early-stage breast cancer. For most women with this condition, the options are 
mastectomy, which involves surgical removal of the entire breast, or lumpectomy, 
which is local excision of the tumor followed by radiation. Clinical trials have shown 
that the two treatments are the same in terms of a woman’s chances of surviving 
her cancer, but they are obviously very different in terms of their effect on her body 
and possibly her sense of well-being.
For women who choose lumpectomy, there is a higher risk that the cancer will recur 
in the same breast. To reduce this risk, most patients who have a lumpectomy also 
undergo radiation treatment. Women who elect mastectomy do not need to worry 
as much about a local recurrence, but mastectomy is more disfiguring, and women 
who choose it will have to undergo more surgery if they wish to have the breast 
reconstructed. Women who have lumpectomy also may need more than one opera-
tion to be sure all of the tumor is removed, and they will usually need weeks of 
radiation treatment. Different women will prefer one option or the other, depending 
upon how much they value preserving their breast, their willingness to undergo 
radiation or more invasive surgery, and the level of uncertainty they are willing to live 
with in terms of their cancer recurring.
Elective tests, procedures, and surgeries like mastectomy and lumpectomy are 
used to treat conditions that are considered “preference-sensitive.”i For such con-
i For preference-sensitive conditions, the rate at which a procedure occurs is sensitive to, or driven by, 
somebody’s preference. In the absence of shared decision-making, it is often the doctor’s preference that 
determines treatment, rather than the patient’s.
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ditions, medical ethics requires that the patient be given the opportunity to help 
make a fully informed choice: to look at the various options and select one with her 
clinician based on her personal values and a sound understanding of the available 
medical evidence. When patients do not have a chance to make a fully informed 
choice, clinicians are at risk of prescribing the wrong treatment to a patient—a treat-
ment that the patient would not have wanted had she been fully informed and given 
the opportunity to share the decision.
The link to practice variation
Patients facing elective procedures—such as surgeries and tests—are not always 
given the chance to understand their choices and share the decision with their 
clinicians. A recent study found that most patients were poorly informed about the 
potential risks and benefits offered by a wide variety of treatments recommended 
by their clinicians, and clinicians did not ensure that their patients fully understood 
their options.2 Other studies have shown that patients who are given the opportunity 
to fully understand their options often make different choices than patients who are 
not fully informed.4
Research suggests that for many preference-sensitive conditions—especially those 
that can be treated with elective surgery—the treatment a patient receives depends 
more on the physician’s recommendation than the patient’s preferences.1 This is 
due in part to the fact that many patients are not even aware that the decision about 
elective surgery is in part theirs to make, and they routinely delegate the decision to 
undergo surgery to their surgeons in the belief that “the doctor knows best.”
Many patients do not realize that their clinician does not always fully understand 
their values and preferences. When this happens, the clinician’s treatment 
recommendations may be different from what their patients would have chosen 
had they been given the opportunity to be fully informed.2 Many clinicians are not 
accustomed to involving their patients in treatment decisions in a meaningful way 
and thus cannot be sure which treatment their patients would prefer.3,5 Clinicians 
also vary widely in their opinions about the best course of treatment; one surgeon 
may believe one procedure is best, while another favors a different approach. This is 
the case more often than patients might think. There are gaps in medical knowledge, 
and sometimes the scientific evidence is not yet sufficient to clarify which treatment 
is safest and most effective for a given condition in an individual patient.6 Even when 
the risks and benefits of a treatment are well documented, physicians have their 
own beliefs about what matters most and often value the possible treatment options 
differently than would their patients.
These differences in clinicians’ personal beliefs and opinions lead to differences in 
the kinds of treatment patients receive in different geographic locations. For exam-
ple, there is considerable disagreement among surgeons about the need for back 
surgery, its effectiveness, and even the best way to diagnose the cause of back pain. 
This lack of agreement stems in part from a lack of studies, called clinical trials, 
which provide the scientific evidence that clinicians need in order to know how best 
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to treat their patients. With no consensus about how to diagnose and treat back pain, 
the rate of back surgery varies a great deal from place to place.ii
On the other hand, when clinicians agree on how to treat a condition, there is often 
relatively little geographic variation in the care patients receive. Take the example 
of hip fracture. Diagnosing a broken hip is not difficult, and all physicians agree that 
patients with a broken hip must be hospitalized and undergo a procedure to repair 
it. Moreover, patients who break their hips always seek medical care. Thus the rate 
of hospitalization for hip fracture is a reflection of the rate of hip fracture itself; and 
this does not vary much from place to place. What variation does exist can be con-
sidered justified, or warranted, because it can be explained on the basis of the rates 
at which hip fractures actually occur in populations.
ii The wide variation in rates of surgeries, tests and other procedures can be due to the opinions of a relatively 
small number of physicians in a community. This was seen in Vermont in the 1970s, where rates of tonsillec-
tomy varied widely in towns that were only a few miles apart. In the town of Waterbury, for example, less than 
20% of children had undergone a tonsillectomy by age 15. In nearby Morrisville, more than 60% of children 
had had their tonsils removed by that age. Two physicians in Morrisville were responsible for the high rate of 
tonsillectomy there. When the physicians in Morrisville learned that children in their town were far more likely 
to undergo the surgery than in the rest of the state, they decided to seek a second opinion before recommend-
ing the surgery. Two years later, the rate of tonsillectomy in Morrisville dropped to 10%.22
WHAT IS A RATE?
A rate measures how often something happens in a defined population. In medicine, a rate is usually expressed as 
the number of events (procedures, tests, etc.) that happen in a given group of people over a given period of time (the 
numerator), divided by the total number of members of the group (the denominator) during that period. For example, 
if there are 1,000 people in a group, and 15 of them undergo back surgery in one year, the rate of back surgery is 15 
per 1,000 for that year. This can also be expressed as a rate of 1.5% (or 1.5 per 100). In this report, the rates are usu-
ally based on the number of procedures performed on Medicare beneficiaries divided by the total number of Medicare 
beneficiaries who live in a given geographic area. Most of the rates in this report are expressed as the number of 
procedures per 1,000 beneficiaries; they are averaged over a five-year period, 2003 to 2007.
These rates have been adjusted for age, sex and race. This means that demographic factors that might affect how 
common a condition is have been taken into account. For example, communities where Medicare beneficiaries are 
older, on average, tend to have more heart disease. That could affect the rate of cardiac bypass surgery, because we 
would expect that communities where heart disease is more common would have more bypass surgery. Adjusting for 
age (and for sex and race, which can also affect the amount of disease) makes it unlikely that the variation we see in 
rates of cardiac bypass surgery in different communities is due to differences in the age composition of the population 
and thus to different rates of heart disease itself. In essence, these adjustments make the results what they would be 
if there were no age, sex or race differences between areas.
Knowing the rate at which a particular procedure occurs among local communities is a way to compare the average 
chance of undergoing that procedure, depending on where one lives. For example, over the five-year period 2003-
2007, the average rate of back surgery among Medicare beneficiaries living in and around Bend, Oregon was 8.6 per 
1,000 beneficiaries, one of the highest rates in the nation. The rate in and around East Long Island, New York was 2.1, 
about a quarter of the rate in Bend. That means a resident of Bend was four times more likely to undergo back surgery 
than a resident of East Long Island. Another way to judge the chance of undergoing a procedure is to compare the 
rate in a given community against the U.S. average. The rate of back surgery in Bend was twice the U.S. average.
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Where you live is what you get
The rates of use of most surgical procedures vary to a much greater extent than the 
rate of hospitalization for hip fracture. What this means is, if you are a patient with 
a surgical condition—a disease or condition that can be treated surgically—your 
chances of having surgery depend in large measure on where you live and which 
clinicians you happen to see. In health care, to a remarkable degree, geography 
is destiny.
Previous editions of the Dartmouth Atlas have documented striking variations in 
the rates of use of elective surgery among the 306 hospital referral regions (HRRs) 
in the United States.iii This edition of the Atlas, which is a collaborative project with 
the Foundation for Informed Medical Decision Making (see box), not only looks 
at the variation in care delivered in HRRs; it also contains information about the 
care delivered in much smaller areas, known as hospital service areas (HSAs), 
which generally encompass geographic areas served by a relatively small number 
of hospitals.iv The Foundation, through its medical editors, is responsible for the 
information regarding the treatment options for the conditions discussed in this 
report. The Dartmouth Atlas Project is responsible for the analysis of the data on 
practice patterns.
By focusing on both hospital referral regions and hospital service areas, this report 
offers individuals information about their chances of undergoing ten surgeries and 
one cancer screening test, depending upon where they live. The information on 
treatment options and local rates of use is intended to help clinicians, patients and 
families understand both the importance of patients’ preferences in making medical 
decisions and the (sometimes wide) variation in rates of these procedures in their 
local communities. Through this understanding, we hope to encourage patients 
and their families to make sure that they are given the chance to be fully informed 
and to share important health care decisions with their clinicians.
The following section, “Variation in Preference-Sensitive Care,” provides information 
about eight different preference-sensitive conditions. It describes the treatment 
options and highlights the trade-offs that patients face in choosing between them. 
It describes the variation in the rates at which ten surgical treatments and one test 
were delivered in the 306 HRRs around the country during the period from 2003 
to 2007. For information about the rate of each procedure or test in each HSA 
in Minnesota, please see the Appendix Table. The data are also available on the 
Dartmouth Atlas web site (www.dartmouthatlas.org).
iii Hospital referral regions are large health care markets that include at least one large referral hospital, such 
as an academic medical center, as well as other community hospitals. For a more complete definition of a 
hospital referral region, go to www.dartmouthatlas.org.
iv Hospital service areas are defined by patterns of use of local hospitals. Most contain only one hospital; and 
most hospital referral regions contain a number of hospital services areas. For example, the Minneapolis 
hospital referral region comprises 61 hospital service areas in Minnesota and Wisconsin. See the Appendix on 
Methods for details on this and other points of methodology.
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THE FOUNDATION FOR INFORMED MEDICAL DECISION MAKING
The Foundation for Informed Medical Decision Making (www.informedmedicaldecisions.org) is a non-profit 
organization dedicated to increasing patient involvement in health care decision-making. Health Dialog Services 
Corporation (Health Dialog) was created to disseminate the material and insights developed by the Foundation. The 
licensing agreement between the Foundation and Health Dialog, its production and distribution partner, provides 
royalties as well as contract funding to develop and maintain Shared Decision-Making® Programs and other decision 
support materials. Health Dialog is a private, wholly owned subsidiary of Bupa, a global health and care company 
headquartered in London, England.
Different readers will find the next section useful for different purposes. Patients 
with one of the conditions discussed may realize that they want to know more 
before they make a decision about how they want to be treated. This section may 
also raise questions patients might want to ask their clinicians in order to help them 
choose the treatment that is right for them.
The variation in rates of different treatments can also inform clinicians, who are 
often unaware that the care in their medical community may differ from that in 
other communities. It can also serve as a reminder to the medical profession of the 
importance of fully informing patients about their treatment choices as an ethical 
standard for clinical decision-making.
The final section, “Ensuring Patients Get the Care They Need and Want,” discusses 
steps patients can take to make sure they get the care they want and need—and 
no more. It also discusses ways physicians and other clinicians can support shared 
decision-making, to ensure that patients make fully informed choices and to reduce 
unwarranted variation in medical practice.
A word of caution: the conditions discussed in this report by no means represent 
an exhaustive list of all the preference-sensitive treatments and tests that vary in 
their rates of use in different communities. There are many more decisions about 
elective procedures and treatments that patients and clinicians should share. Many 
decisions—such as prescribing drugs and undergoing screening tests—should be 
shared between well-informed patients and their clinicians. Patients should also 
be cautioned against considering the information about individual conditions and 
possible treatments presented in this report as sufficient for making decisions about 
preference-sensitive care. Patients should go to their clinicians for more information.
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A word about the study population. Variation in the procedure rates 
presented in this report was measured across a national sample of fee-for-
service Medicare beneficiaries (the denominator in rate calculations). While 
this population includes a mixture of illness types—different stages of breast 
cancer, for example—most of the variation in procedure rates occurs within 
the population diagnosed with the above listed illnesses. An exception is that 
prostate cancer screening (prostate-specific antigen testing) was measured in 
men without any evidence of prior prostate disease (see page 46).
Variation in Preference-Sensitive Care
The information in this section summarizes the major treatment options available 
for most patients with one of eight preference-sensitive conditions:
•	 Early-stage breast cancer (treatment)
•	 Stable angina, or chest pain due to coronary artery disease
•	 Low back pain
•	 Arthritis of the knee or hip 
•	 Carotid artery disease
•	 Gallstones
•	 Enlarged prostate (benign prostatic hyperplasia)
•	 Early-stage prostate cancer (screening and treatment)
Readers can find an overview of each condition, prepared under the guidance of 
the Foundation for Informed Medical Decision Making. Each overview summarizes 
the major treatment options and the trade-offs patients face. Readers can also find 
a map showing the variation in rates of use in the 306 HRRs for each condition, 
prepared by the Dartmouth Atlas team. Each map shows the variation across the 
U.S. and indicates the chances of receiving one treatment or another, depending 
upon location. To find out the rate for each procedure in your community, go to 
the Appendix Table, which shows the rates for the 121 hospital service areas in 
Minnesota. Rates for all HRRs and HSAs will be available at the Dartmouth Atlas 
web site (www.dartmouthatlas.org).
The surgical rates are for procedures performed during the calendar years 2003-
2007 for patients enrolled in traditional (fee-for-service) Medicare. The data for PSA 
testing are for men age 68-74 enrolled in traditional Medicare in 2008. These are 
the most recent dates for which Atlas data are available. All data are based on 
Medicare claims, and rates are age, race and, when appropriate, sex adjusted (see 
the Appendix on Methods). Although studies in Michigan, California and Louisiana 
suggest that the variations in rates among communities are similar for patients 
under 65, data are not yet available in most parts of the country.
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Early-Stage Breast Cancer
Early-stage breast cancer is the second most common cancer among women (after 
lung cancer). Most early-stage breast cancers are curable, and women have a 
choice between two equally effective surgical treatments. The majority of women 
treated for early-stage breast cancer will die of some other cause.
How early-stage breast cancer is diagnosed and treated
Early-stage breast cancer is most often diagnosed with a biopsy (removal and 
examination of a small sample of breast tissue) following a screening mammogram, 
and patients must choose between mastectomy and lumpectomy. Mastectomy 
removes the entire breast. Lumpectomy, also known as breast-conserving surgery, 
removes only the tumor and a bit of surrounding tissue. Women who choose 
lumpectomy usually receive radiation therapy after surgery to reduce the risk that 
the tumor will recur in the same location. Most women who undergo mastectomy do 
not have radiation treatment. For almost all women with early-stage breast cancer, 
mastectomy and lumpectomy followed by radiation are equally effective in reducing 
their chances of dying of breast cancer.
Patient choices
Since both modes of treatment offer the same odds in terms of reducing a woman’s 
risk of death from breast cancer, which treatment she chooses depends upon her 
feelings about her appearance after surgery, the time and energy required for each 
treatment option, and the risk of a local recurrence. Mastectomy usually involves 
one operation and reduces the worry that the cancer might recur in the same breast. 
Women who choose mastectomy must also decide if they want to undergo breast 
reconstruction.
Women who value their breasts highly, and who can accept a slightly higher chance 
of cancer coming back in the treated breast, may decide to choose lumpectomy, 
which can sometimes be done under local anesthesia in the surgeon’s office. 
Lumpectomy may require more than one surgery to ensure that all of the cancer has 
been removed. Women who choose lumpectomy usually undergo radiation therapy. 
This may involve multiple trips to the hospital or clinic. Radiation reduces—but does 
not eliminate—the chance that cancer will return in the treated breast, and it is not 
safe for some breast cancer patients. Women who feel they would have greater 
peace of mind if the breast is removed, or who do not want to undergo radiation 
treatment, may decide that mastectomy is a better choice.
There was a high degree of variation in rates of mastectomy across the U.S. during 
the period 2003-07 (Map 1). This variation is a reflection of several factors that go 
into the choice between mastectomy and lumpectomy. Physicians have different 
views about which surgery they recommend, and their opinions do not always take 
into account what patients want. In recent years, some breast surgeons have moved 
away from performing mastectomies in the belief that lumpectomies are better for 
most women, regardless of whether patients prefer it. At least one study has found a 
Early-Stage
Breast Cancer
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gap between what women with early breast cancer value and what their physicians 
and nurses think patients want.7
Patients also vary in their choices. Some studies have found that the choice of 
lumpectomy is strongly associated with more years of formal education. Another 
way of saying this is that more educated women may be less likely to choose 
mastectomy. But other studies have shown that women who participate in the 
decision about breast surgery are more likely to choose mastectomy than women 
whose surgeons make the decision.8,9
The person in the best position to decide which surgery to undergo is the patient. 
Women who are active participants in the decision about how to treat early-stage 
breast cancer are more satisfied with their treatment than women who are not 
active participants, regardless of which treatment they received.8,9
Map 1. Mastectomy per 1,000 female Medicare beneficiaries among hospital referral regions (2003-07)
The colors on the map represent the rates of mastectomy (surgical removal of the breast) per 1,000 female Medicare beneficia-
ries in each of the 306 HRRs. Rates are adjusted for age and race. The highest rate, 2.5 surgeries per 1,000 female Medicare 
beneficiaries, was seen in the Victoria, Texas HRR. The lowest rate, 0.3 surgeries per 1,000, was seen in the Muncie, Indiana 
HRR. In other words, women over 65 living in Victoria were more than seven times more likely to undergo mastectomy for early-
stage breast cancer than women living in Muncie. The average rate of mastectomy was 1.1 per 1,000 in the entire U.S.
The greatest variation within a single region was seen in Raleigh, North Carolina, where the rate of mastectomy ranged from 0.4 
per 1,000, in the Wilson HSA to 2.7 per 1,000 in the Goldsboro HSA.
Early-Stage
Breast Cancer
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Stable Angina
The coronary arteries supply blood to the heart muscle. Fatty deposits, called 
plaques, sometimes form inside the arteries; this is called coronary artery disease. 
If the plaques narrow the artery enough that it is unable to deliver enough oxygen 
to the heart muscle, patients can experience chest pain called angina.
There are two types of angina. A person is said to have “unstable angina” if he or she 
has pain that is unpredictable, unexpected or difficult to control. This type of angina 
is an emergency and can signal a heart attack. However, chest pain that occurs at 
predictable times, such as with exertion—walking up stairs, for example, or lifting 
something heavy—is called “stable angina.” The severity and associated disability 
can vary, but stable angina is usually relieved by resting or taking nitroglycerin.
How stable angina is diagnosed and treated
Once an emergency (like a heart attack) has been ruled out, it is important to 
determine the cause of the chest pain. Several conditions that have nothing to do 
with the heart can cause chest pain, such as severe heartburn or chest muscle 
strain. Tests may be done to determine if the chest pain is due to coronary artery 
disease, often starting with an exercise stress test.
Once coronary artery disease is diagnosed, even when there is no angina, patients 
are offered medical therapy to reduce their chances of a heart attack and death. 
Medical therapy typically combines lifestyle changes, such as quitting smoking, 
losing weight and exercising, with drugs to control blood pressure, manage 
cholesterol and prevent blood clots from forming. Patients who have stable angina 
are often given additional drugs to reduce its frequency and discomfort. For some, 
medical therapy alone provides complete relief from stable angina.
Clinicians may also recommend more invasive procedures for patients with coronary 
artery disease. One procedure is balloon angioplasty with stents, which involves 
threading a small tube into the heart vessel (coronary artery) with the fatty block-
age, or plaque. A tiny balloon is inflated inside the tube, compressing the plaque 
against the wall of the vessel, and then leaving behind another small tube—called 
a stent—to keep the vessel open. This and related procedures are often referred 
to as percutaneous coronary intervention, or PCI. When used in addition to medi-
cal therapy, PCI can provide greater relief from angina than can medical therapy 
alone. However, the procedure also has short-term risks; it can sometimes cause 
heart attacks, strokes or even death. Another procedure to treat large blockages, 
called coronary artery bypass surgery, or CABG, is even more effective at relieving 
stable angina, although it has more short-term risks and requires a hospital stay 
and recovery period.
For most people, meaning those without severe disease, PCI and CABG do not 
prevent heart attacks or improve survival compared to medical therapy alone. 
These procedures treat large blockages—the ones that typically cause angina—
while heart attacks are often caused by blockages from smaller plaques. However, 
for people with severe disease (those with large blockages in critical arteries, or 
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large blockages in addition to either heart failure or diabetes), PCI and CABG do 
improve survival compared to medical therapy alone.
Patient choices
While all patients with stable angina will need to take medications, patients can 
choose whether to have PCI or CABG in addition to their prescriptions. For those 
who do not have severe disease—the majority—these procedures will not, on 
average, prolong survival, so for these people, the decision may be about how 
they feel about their angina. If medical therapy cannot adequately address their 
angina symptoms, they may look to a procedure. The patient will have to weigh 
the increased likelihood of angina relief against the potential risks and burdens of 
the procedures. People with severe disease also have the survival benefit of PCI 
and CABG to consider compared to medical therapy alone. The trade-offs may 
vary depending on the person; for instance, people with diabetes are more likely 
to experience harm during CABG. It is also important to realize that people may 
Map 2. Coronary artery bypass surgery (CABG) per 1,000 Medicare beneficiaries among hospital referral regions  
(2003-07)
The colors on the map represent the rates of CABG surgery per 1,000 Medicare beneficiaries in each HRR. Rates are adjusted 
for age, sex and race. The highest rate, 8.9 procedures per 1,000 beneficiaries, was seen in McAllen, Texas. The lowest rate, 1.9 
procedures per 1,000, was seen in Pueblo, Colorado. In other words, patients in the McAllen HRR were more than four times more 
likely than patients in the Pueblo HRR to undergo CABG during 2003-07. The national average rate of CABG was 4.6 per 1,000. 
The greatest variation within a single HRR was seen in Denver, where the rate of CABG surgery ranged from less than 2 per 1,000 
beneficiaries in the Steamboat Springs, Colorado HSA to more than 7 per 1,000 in the McCook, Nebraska HSA.v
 vHospital service areas can belong to hospital referral regions in different states if patients frequently cross state lines to receive care at the closest tertiary care hospital.
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not know whether or not they have severe disease unless they choose to have 
additional tests, which have their own short-term risks.
Physicians do not always agree on the best course of treatment for patients 
with stable angina, which is reflected in the degree of variation in rates; rates 
of CABG varied nearly fivefold across HRRs (Map 2), and rates of PCI varied 
more than tenfold (Map 3). Some believe that, compared to medical therapy alone, 
heart procedures prolong survival, even in people without severe disease. Many 
patients also have a difficult time understanding why a procedure that opens blood 
vessels would not be the best option.10 The decision on how to treat stable angina 
is best shared between the patient and the physician. The doctor can help the 
patient understand the pros and cons of each treatment choice for their particular 
situation: for instance, how their diabetes influences the trade-offs in benefit and 
risk. But only the patient knows how bothersome the symptoms are and how he 
or she feels about the pros and cons of each treatment option. For some people, 
a few angina attacks are tolerable, as long as the pain can be relieved with rest or 
nitroglycerin. For other people, the possibility of greater angina relief makes the 
short-term risks of PCI and CABG worth taking.
Map 3. Percutaneous coronary intervention (PCI) per 1,000 Medicare beneficiaries among hospital referral regions 
(2003-07)
The different colors represent the rates of PCI per 1,000 Medicare beneficiaries in each HRR. Rates are adjusted for age, sex and 
race. The highest rate, 37.3 procedures per 1,000 beneficiaries, was seen in the Elyria, Ohio HRR. The lowest rate, 3.6 procedures 
per 1,000, was seen in Honolulu. Medicare beneficiaries living in the Elyria HRR were more than ten times more likely to undergo 
PCI than beneficiaries living in Honolulu. The rate in Elyria was also more than three times the average rate across the entire U.S 
(11.3 per 1,000). The greatest variation within a single HRR was seen in Napa, California, where the rate of PCI ranged from a little 
more than 5 per 1,000 beneficiaries in the Fort Bragg HSA to nearly 42 in the Clearlake HSA.
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Low Back Pain
Low back pain is a nearly universal complaint that afflicts most American adults 
at some point in their lives. Most episodes of back pain go away in time with no 
treatment, even when the pain is severe or when it persists for weeks or months. 
The majority of back pain is termed “non-specific,” which means it cannot be traced 
to a specific cause. Back pain that has lasted up to four weeks is called “acute.” 
Pain that lasts more than four weeks may be considered “sub-acute” or “chronic,” 
depending upon the duration. While back pain is common, diagnosing its specific 
cause can be difficult. Less than 10% of people who visit their clinicians because of 
back pain have an identifiable cause. For the vast majority, the cause of their pain 
is unknown.
How low back pain is diagnosed and treated
After first ruling out a serious cause for acute back pain (for example, a spine 
infection or cancer), physicians and nurses will often recommend over-the-counter 
pain medication such as acetaminophen, ibuprofen or naproxen. Spinal manipulation 
may also help. Bed rest and inactivity will delay recovery. If the pain is severe and 
interferes with sleep or the ability to work, physicians sometimes recommend short 
courses of drugs that relax muscles, such as cyclobenzaprine, or pain medications 
that contain morphine-like drugs known as opioids, such as codeine.
For non-specific back pain that lasts beyond the first month, there are a variety 
of other treatments, including physical therapy, exercise, massage, acupuncture, 
yoga, relaxation therapy and cognitive behavioral therapy. There is little evidence 
that surgery is better than non-surgical treatment for chronic or persistent non-
specific low back pain in patients who do not also have leg pain.
Sometimes a herniated or “ruptured” disc in the spine can cause sciatica, pain 
that usually extends down the back of the legs and may occur along with back 
pain. Herniated discs are visible on advanced imaging tests—such as a magnetic 
resonance image (MRI) or a computed tomography (CT) scan—but not on plain 
X-rays. These discs sit between the vertebrae to cushion the impact of bone 
on bone. They are filled with a soft, jelly-like material, which can bulge or break 
out from the fibrous covering of the disc, irritating nerves and causing sciatica. 
Herniated discs are not believed to cause low back pain, only sciatica. Herniated 
discs are most commonly diagnosed in people aged 30-50 years and affect men 
and women about equally.
If the pain persists for more than a month, the patient’s physician may order an 
imaging test such as an MRI or CT scan. Imaging tests are usually not helpful in 
diagnosing and treating back pain and may even be misleading. Some people with 
severe back pain have normal spine imaging tests. On the other hand, more than 
half of people without back pain have a bulging or herniated disc on imaging scans, 
so the results of an imaging test alone are not enough to determine a source of the 
pain or indicate a particular treatment. 
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Map 4. Back surgery per 1,000 Medicare beneficiaries among hospital referral regions (2003-07)
The colors on the map represent the rates of back surgery per 1,000 Medicare beneficiaries in each HRR. Rates are adjusted for 
age, sex and race. The highest rate, 10.0 surgeries per 1,000 Medicare beneficiaries, was seen in Casper, Wyoming. This rate was 
nearly six times higher than the lowest rate, 1.7 surgeries per 1,000, seen in the Honolulu HRR. The average rate of back surgery 
in the entire U.S. was 4.3 per 1,000.
The greatest variation within a single region was seen in Lexington, Kentucky, where the rate of back surgery ranged from 0.8 per 
1,000 beneficiaries in the Jackson HSA to 5.4 per 1,000 in the Somerset HSA.
Back pain and leg pain may be related to arthritis, which can cause bony growths 
on the vertebrae that press on nerves or irritate them. This condition is known 
as spinal stenosis (“stenosis” means “narrowing”). Pain from spinal stenosis can 
radiate down the legs and feel like numbness or tingling, and unpleasant muscle 
spasms are common. Spinal stenosis most often occurs among people in their 50s 
and older and appears to be more common in women than men.
The pain associated with herniated disc usually goes away on its own. Some people 
with mild to moderately symptomatic stenosis get better with no treatment, some 
get worse, and most stay about the same. Strengthening and aerobic activities may 
help reduce pain and improve the ability to do physical activities for some people 
with spinal stenosis. Medications may also help with short-term flare-ups, but the 
drugs can be habit forming and cause side effects. Steroid injections may relieve 
pain temporarily, although it is not known how often they can be taken safely.
Low Back Pain
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There are several surgical procedures used to treat herniated disc and spinal 
stenosis. Until recently, there has been limited scientific evidence to show when 
surgery might be effective. For herniated disc, surgery appears to be more helpful 
for leg pain than back pain. For those with leg pain, surgery may offer slightly 
faster relief than non-surgical treatment, but it is no more effective over time. Some 
patients get no relief at all or suffer more pain after surgery.11-13
Research now suggests that patients with spinal stenosis may find more pain relief 
from surgery than from non-surgical treatment.14,15 However, surgery has more 
risks, and a significant number of people who undergo one type of surgery, spinal 
fusion, have additional back surgeries to treat ongoing pain.
Patient choices
Rates of back surgery varied nearly sixfold in different parts of the country during 
2003-07 (Map 4). Because patients differ in both their perceptions of pain and the 
disability it can cause and their preferences for treatment, they should not have 
surgery based solely on a diagnosis of chronic low back pain, spinal stenosis or 
herniated disc. For some, the pain and lack of mobility are not severe enough to 
warrant major surgery, which involves real risks. Older patients may have other 
serious conditions, such as heart disease, that may also restrict their movements 
or increase the risks of surgery, so back surgery might not offer a substantial 
improvement in their quality of life. For some people with herniated disc or spinal 
stenosis, surgery may seem like the right choice despite the risks and uncertainty 
about the outcome.
Low Back Pain
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Osteoarthritis of the Knee and Hip Joints
As people age, their knee and hip joints may become stiff and sore due to 
osteoarthritis, or degeneration of the joint cartilage. Painful osteoarthritis can limit 
mobility, and pain medications and other non-surgical approaches may have limited 
power to relieve symptoms. For patients suffering from severe osteoarthritis pain, 
surgeons may recommend total joint replacement. This is a major surgical procedure 
that removes the patient’s joint and replaces it with a prosthetic (artificial) device.
How osteoarthritis is diagnosed and treated
Osteoarthritis of the hip or knee is usually diagnosed on the basis of the patient’s 
symptoms, followed by an imaging test such as an X-ray or a magnetic resonance 
image (MRI), which can show damage to the cartilage and bone in the joint. But 
the severity of the damage that appears on an image is not a sufficient reason for 
recommending treatment. Some patients, even those with severe symptoms and 
X-ray or MRI evidence of damage to the joint, are not bothered enough by their 
condition to want to undergo surgery. A recent Canadian study found that only 
about 35% of patients with severe symptoms of arthritis and significant damage to 
their joint definitely or probably wanted surgery at that time. Most were unwilling to 
have it, or unsure.16 Moreover, patients with severe degeneration on an X-ray or 
MRI may experience little pain, while the joints of some patients with severe pain 
may show little degeneration on images.
There are several ways to treat knee and hip pain, each of which has potential 
benefits and risks. Exercise can help reduce stiffness, strengthen supporting 
muscles, and boost energy level and mood. Clinicians may recommend that patients 
with knee osteoarthritis lose weight, which can relieve stress on the knees and 
poses very little risk (and may offer other health benefits). It is not known whether 
weight loss helps hip pain.
Pain medications such as aspirin, ibuprofen, naproxen and acetaminophen may 
relieve pain, but many pain medications can irritate the stomach when taken for 
long periods of time or in high doses. In rare cases, this irritation can cause life-
threatening bleeding. Using a cane or walker can improve mobility but will not 
relieve pain.
For patients with severe osteoarthritis, total joint replacement usually relieves pain 
and improves mobility. Like any major surgery, joint replacement can pose serious 
risks, including death, a blood clot in the lung, and infection. The initial rehabilitation 
period for total joint replacement may last weeks, during which time mobility is 
severely limited. It may take another two to three months before the patient can 
resume most of his or her usual daily activities. For about 10% of patients, surgery 
does not relieve pain and may make it worse. A few patients may experience 
problems due to the prosthetic joint itself. Eventually the artificial joint may wear 
out, and the patient may face the same decision about surgery when he or she is 
older and may be less able to undergo surgery safely.
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Patient choices
Rates of surgery to replace a hip or knee varied approximately fivefold across HRRs 
during 2003-07 (Maps 5 and 6), reflecting the lack of agreement about how best 
to treat patients with osteoarthritis. The decision about whether or not to undergo 
joint replacement surgery should be shared between the patient and his or her 
clinician. For some patients, the pain and activity limitations from osteoarthritis are 
not severe enough to warrant major surgery, and they would prefer to continue 
with non-surgical treatments or try losing weight. Some patients have other serious 
conditions, such as lung disease, that make surgery more dangerous. For others, 
the risks of surgery and the time needed for rehabilitation are worth taking.
Map 5. Total knee replacement per 1,000 Medicare beneficiaries among hospital referral regions (2003-07)
Each area on the map represents an HRR. The color indicates the rate of total knee replacement per 1,000 Medicare beneficiaries 
in that HRR. Rates are adjusted for age, sex and race. There was considerable variation in the rates at which Medicare beneficiaries 
underwent knee replacement during 2003-07. Medicare beneficiaries living in the Lincoln, Nebraska HRR were nearly five times 
more likely to undergo joint replacement surgery for osteoarthritis of the knee than beneficiaries living in Honolulu (13.8 per 1,000 
beneficiaries versus 2.9 per 1,000). The national average rate of knee replacement was 8.0 per 1,000.
The greatest variation within a single HRR was seen in Charleston, West Virginia, where the rate of knee replacement surgery 
ranged from 2.7 per 1,000 beneficiaries in the Williamson HSA to 9.2 per 1,000 beneficiaries in the Hurricane HSA.
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Map 6. Total hip replacement per 1,000 Medicare beneficiaries among hospital referral regions (2003-07)
Each area on the map represents an HRR. The color indicates the rate of total hip replacement per 1,000 Medicare beneficiaries 
in that HRR. Rates are adjusted for age, sex and race. There was considerable variation in the rate at which Medicare beneficiaries 
underwent hip replacement. The highest rate, 5.3 surgeries per 1,000 beneficiaries, was seen in the Sioux City, Iowa HRR; the 
lowest rate, 1.0 procedure per 1,000, was seen in Honolulu. In other words, beneficiaries living in and around Sioux City were more 
than five times more likely to undergo the surgery than beneficiaries living in Honolulu. The average rate of hip replacement in the 
U.S. was 3.3 per 1,000 Medicare beneficiaries.
Even within a single HRR, there was substantial variation in rates of hip replacement. For example, in the San Diego region, the 
rate of hip replacement surgery ranged from less than 1 procedure per 1,000 beneficiaries in and around the community of National 
City to nearly 7 per 1,000 beneficiaries in nearby Coronado.
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Carotid Artery Disease
The carotid arteries supply blood to the brain. Fatty deposits called plaques sometimes 
form inside them. When they do, the condition is called carotid artery disease or 
carotid stenosis (“stenosis” means “narrowing”). Carotid artery disease often causes 
no symptoms. Many people learn they have the condition only after they have a test, 
such as an ultrasound, that shows how well blood is flowing in the arteries.
Having carotid artery disease means a patient is at increased risk of having a stroke 
or a transient ischemic attack (TIA). A stroke happens when blood flow to a part 
of the brain is blocked by a blood clot or a piece of plaque that has broken off 
and traveled up into the smaller blood vessels in the brain. If a part of the brain 
goes without blood for too long, the cells in that area die. The effects may last for 
days, weeks, months, or the rest of the patient’s life. A TIA is a temporary stroke. A 
clot or plaque blocks the flow of blood for a short time and then dissolves, and the 
symptoms go away in a matter of minutes or hours.
Even though carotid artery disease can increase a person’s risk of stroke, most 
people with the condition never have one. Out of 100 people with carotid artery 
disease who take medication to lower their risk and have not had a stroke or TIA in 
the past 12 months, a little more than 2 will have a stroke within the next year, and 
98 will not.17
How carotid artery disease is diagnosed and treated
Carotid artery disease is diagnosed with various imaging tests including ultrasound, 
which gives a picture of the insides of the arteries in the neck and can show whether 
and by how much they are narrowed by plaque. Studies show that medications 
that lower blood pressure and help prevent blood clots can lower the risk of stroke. 
Quitting smoking and getting regular physical activity can also lower the risk of stroke, 
as can carotid artery surgery. The two main surgeries are carotid endarterectomy 
and stenting. During an endarterectomy, the surgeon makes an incision in the neck, 
opens the artery, removes the plaque, and closes the artery back up. Carotid stenting 
is a relatively new procedure. The surgeon inserts a stent (a tiny metal tube) to keep 
the artery open. Both procedures involve a stay in the hospital.
In asymptomatic patients—those who have not had a stroke or TIA within the past 
12 months—carotid endarterectomy surgery can reduce the risk of stroke more than 
medications alone (to about 6% over five years versus about 12% over five years 
for medication alone). But surgery itself can cause a stroke, a heart attack or death. 
Even though surgery can lower the chance of stroke, there is no strong evidence 
that people who have it live longer than people who do not.17
Patient choices
Once the diagnosis of carotid stenosis is made, the patient has the option to be 
treated medically—with drugs and lifestyle changes—or with medical treatment plus 
surgery. Medical treatment alone can help, and surgery reduces the risk further. 
But there is a trade-off, because surgery also increases the short-term risk of 
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stroke, heart attack and death. In addition, only 15% of all strokes are due to carotid 
artery disease. Other health conditions, such as heart, lung or kidney disease and 
diabetes, can also cause a stroke, and surgery does not reduce the risk of stroke 
from these causes.
Physicians differ in the value they place on the short-term risks of surgery versus 
the long-term risks of stroke. There is also disagreement among physicians about 
the value of carotid endarterectomy versus carotid stenting. The very high variation 
in rates of carotid endarterectomy in different parts of the country (Map 7) is likely 
due in part to the range of opinions about the value of surgery among clinicians.
The decision to proceed or not with carotid artery surgery should be shared between 
the patient and clinician. For some patients, the potential long-term benefits of 
carotid artery surgery will outweigh the possible short-term risks. For others, the 
immediate risks of surgery will outweigh the long-term benefits, and they would 
prefer to continue with medical treatment.
Map 7. Carotid endarterectomy per 1,000 Medicare beneficiaries among hospital referral regions (2003-07)
The colors on the map represent the rates of carotid endarterectomy per 1,000 Medicare beneficiaries in each HRR. Rates are 
adjusted for age, sex and race. The highest rate, 6.0 surgeries per 1,000 beneficiaries, was seen in the Beaumont, Texas HRR. The 
lowest rate, 0.5 surgeries per 1,000, was seen in Honolulu; Medicare beneficiaries living in the Honolulu HRR were twelve times 
more likely to undergo the procedure than beneficiaries living in Beaumont. The average rate of carotid endarterectomy surgery was 
2.7 per 1,000 in the entire U.S. The greatest variation within a single HRR was seen in Albuquerque, where the rate of surgery ranged 
from a little more than 0.5 per 1,000 beneficiaries in the Gallup/Crownpoint area to nearly 4.5 per 1,000 beneficiaries in Roswell.
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Gallstones
Gallstone disease is one of the most common and costly of all digestive disorders. 
Gallstones are hard, pebble-like deposits that can form in the gallbladder, a pear-
shaped sac located in the upper abdomen that secretes bile into the small intestine 
to aid the digestion of fats. Gallstones can be as small as a grain of sand or as big 
as a golf ball. They form for unknown reasons, and they are most common among 
women, certain ethnic groups, people over 40, and those who are overweight, 
pregnant, have diabetes, take certain medications (for example, birth control pills) 
or lose a lot of weight quickly.
How gallstones are diagnosed and treated
In the past, gallstones were generally diagnosed when a patient suffered a 
gallbladder “attack,” an episode of moderate to severe abdominal pain caused by 
one of two conditions: biliary colic or acute cholecystitis. Biliary colic, which occurs 
when the stone or stones irritate the lining of the gut, generally goes away on 
its own in a matter of minutes to hours. In acute cholecystitis, the stone blocks a 
bile duct, causing the gallbladder to become inflamed and sometimes infected. 
Complications of gallstones can include jaundice (yellowing of the skin and whites 
of the eyes), fever and acute pancreatitis (inflammation of the pancreas).
These days, most gallstones are detected as “silent gallstones,” meaning they do 
not cause symptoms. The diagnosis is usually made when the patient is undergoing 
an imaging test for another condition. Gallstones are diagnosed using ultrasound, 
X-ray, computed tomography (CT) scan or another method of imaging. Many people 
have gallstones and never have symptoms.
Patients with gallstones and no symptoms (“silent gallstones”) do not require 
treatment; rather, they should be educated about the symptoms of gallstone disease 
and when to seek treatment if symptoms occur. Patients who suffer from gallstones 
that cause symptoms (biliary colic or acute cholecystitis) may want to consider the 
various treatment options: medications, minimally invasive procedures and surgery. 
Some kinds of gallstones, which are made of cholesterol, can be treated with drugs 
that dissolve cholesterol. Gallstones are sometimes broken up using shock wave 
lithotripsy, a powerful beam of sound. Alternatively, the gallbladder can be surgically 
removed (cholecystectomy) to prevent future attacks. In rare cases, a stone blocks 
the bile duct completely, and surgery must be performed immediately to prevent 
injury to the pancreas.
The gallbladder is commonly removed with minimally invasive (laparascopic) 
surgery. Compared with open surgery, laparascopic surgery often involves less 
post-operative pain, a faster recovery and less risk, unless the patient has coronary 
artery disease, chronic obstructive pulmonary disease or previous upper abdominal 
surgeries.
Gallstones
Embargoed until 12:01am ET, February 24 2011
A REPORT OF THE DARTmOuTH ATlAs PROJECT  23 
Map 8. Cholecystectomy per 1,000 Medicare beneficiaries among hospital referral regions (2003-07)
The colors on the map represent the rates of cholecystectomy per 1,000 Medicare beneficiaries in each HRR. Rates are adjusted 
for age, sex and race. The highest rate, 6.8 procedures per 1,000 Medicare beneficiaries, was seen in the McAllen, Texas HRR. 
The lowest rate, 2.4 procedures per 1,000, was seen in the Mason City, Iowa HRR. Medicare beneficiaries living in and around 
McAllen, Texas were nearly three times more likely to undergo gallbladder surgery than beneficiaries living in Mason City during 
2003-07. The average rate of gallbladder surgery in the entire U.S. was 4.0 per 1,000. The greatest variation within a single HRR 
was seen in Minneapolis, where the rate of gallbladder surgery ranged from 1.9 per 1,000 beneficiaries in the Aitkin HSA to 10.3 
per 1,000 in the Wadena HSA.
Patient choices
Many people who have been diagnosed with silent gallstones will never suffer any 
symptoms, and choosing no treatment at all is an option. People who have suffered 
an episode of biliary colic or acute cholecystitis may choose watchful waiting, 
which simply means waiting until another attack and then deciding if they wish to 
be treated; or they can consider being treated immediately.
The rate of gallbladder surgery varies widely in different parts of the U.S. (Map 8). 
Much of this variation appears to be due to differences of opinion among clinicians. 
Some surgeons recommend that any patient who has gallstones, or has suffered a 
single gallbladder attack, have their gallbladder removed as a precaution against a 
future attack requiring emergency surgery. Many believe that it is better to remove 
the gallbladder when the patient is younger and less likely to suffer complications. 
Other physicians think it is better to wait, because most patients will not suffer an 
attack in the future, especially those who have silent gallstones.
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The person in the best position to choose among these options is the patient. Some 
with silent gallstones may decide that the risk of a first attack is low enough that 
they would prefer not to undergo surgery. Even patients who have experienced an 
episode of biliary colic or acute cholecystitis may want to try drugs, dietary changes 
or shock wave lithotripsy before they consider surgery; or they may be suffering 
from other conditions that are more worrisome than a possible gallbladder attack. 
Others may choose to undergo surgery to forestall any possibility of biliary colic or 
acute cholecystitis.
Gallstones
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Enlarged Prostate (Benign Prostatic Hyperplasia)
The prostate is a gland that sits below a man’s bladder and makes some of the 
fluid (semen) that carries sperm. The prostate surrounds the urethra, the tube that 
carries urine and semen down the penis and out of the body. As men age, the 
prostate often enlarges, pressing on the urethra and making it more difficult to 
urinate. This condition, called benign prostatic hyperplasia, or BPH, is not cancer. 
Symptoms of BPH are very common in older men.
How benign prostatic hyperplasia is diagnosed and treated
BPH can cause a variety of symptoms. Men may feel the urge to urinate but find it 
takes several seconds for the flow to begin. The flow may be slow, it may start and 
stop, and men may feel the need urinate more often during the day and at night, 
and with greater urgency. Many men have an enlarged prostate for years with no 
symptoms, while others may develop severe symptoms over time. Others may have 
similar urinary symptoms but no enlarged prostate.
Clinicians diagnose BPH by first asking a man about his symptoms. This is usually 
followed by digital rectal exam, which involves the clinician inserting a gloved finger 
into the rectum and feeling the prostate gland through the rectum wall. The clinician 
may perform other tests such as a urinalysis or measuring the flow of urine.
An enlarged prostate can lead to other complications such as deteriorating bladder 
muscles, bladder stones, bladder infection and blood in the urine. In some cases, 
a man may become unable to urinate at all, a complication known as acute urinary 
retention. To treat this condition, a catheter will be inserted into the bladder to allow 
urine to drain. Very rarely, an enlarged prostate may lead to kidney failure or serious 
infection.
For men with symptoms, there are a variety of treatment options available, including 
watchful waiting, drug treatments, minimally invasive therapies and surgery. All 
have benefits and risks. In general, the treatments that provide the most symptom 
relief also have the highest risks.
Watchful waiting means that both the clinician and patient monitor symptoms. If 
symptoms worsen, or if they become too bothersome, the man can decide on a 
different course of treatment. The risks of watchful waiting include acute urinary 
retention and the chance that treatment done sometime in the future may provide 
less symptom relief than it might have had it been done sooner. Drugs such as alpha 
blockers, reductase inhibitors, or a combination of the two can prevent symptoms 
of BPH from worsening and provide adequate symptom relief for some men. Side 
effects caused by these medications go away when they are stopped. Minimally 
invasive therapies, such as radio waves and laser treatment, destroy prostate 
tissue around the urethra. They provide more symptom relief than medication but 
less than surgery. There are also more risks associated with these therapies than 
with medication but less than the risks associated with surgery.
Enlarged
Prostate
Embargoed until 12:01am ET, February 24 2011
A Report of the Dartmouth Atlas Project
26 ImPROVING PATIENT DECIsION-mAKING IN HEAlTH CARE
Of all the treatment options, surgery offers the best chance for improved symptoms, 
along with the highest risk of complications and side effects. The most common 
type of surgery is called a transurethral resection of the prostate, or TURP. The 
most common complication of TURP surgery is retrograde ejaculation or “dry 
orgasm.” This happens when the bladder fails to close when a man ejaculates and 
semen goes back into the bladder instead of out the penis. This permanent side 
effect occurs in more than 50% of men who have TURP surgery.
Patient choices
Clinicians have different opinions about the best way to treat BPH. Some may 
recommend surgery in order to prevent acute urinary retention, which is rarely 
dangerous but is quite uncomfortable and requires immediate treatment. Other 
clinicians suggest non-surgical remedies unless the man’s symptoms have become 
extremely severe. These differences of opinion likely contribute to the fivefold 
variation in rates of TURP, the most common surgery for BPH (Map 9).
However, because men with BPH differ in their perceptions of how bothersome 
their symptoms are and their preferences for treatment, clinicians cannot judge 
when or even if a patient should have surgery based on a diagnosis of BPH alone. 
Which treatment a man chooses, if any, should depend upon how bothersome his 
symptoms are to him, his level of concern about the possibility of his condition 
worsening, and his concern about the risks and side effects of surgery. For some 
men, BPH symptoms are not severe or sufficiently troubling to them to warrant 
surgery. These men would prefer to continue with less invasive treatments such as 
watchful waiting or drugs. For men who find their symptoms especially bothersome, 
the risks of surgery may seem worth taking, particularly if they have already tried 
other treatments that have failed.
Enlarged
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Map 9. Transurethral resection of the prostate (TURP) for benign prostatic hyperplasia (BPH) per 1,000 male Medicare 
beneficiaries among hospital referral regions (2003-07)
The colors on the map represent the rates of TURP for BPH per 1,000 male Medicare beneficiaries in each HRR. Rates are adjusted 
for age and race. Rates of TURP varied widely across the U.S. during 2003-07. The highest rate, 9.5 procedures per 1,000 male 
Medicare beneficiaries, was seen in the Idaho Falls, Idaho HRR. This rate was more than five times higher than the lowest rate, 1.7 
surgeries per 1,000, in the Terre Haute, Indiana HRR. The national average rate of TURP was 4.3 per 1,000.
The greatest variation within a single hospital referral region was seen in Salt Lake City, where the rate of surgery ranged from less 
than 1 per 1,000 male beneficiaries in the St. George, Utah HSA to more than 11 per 1,000 male beneficiaries in the Rock Springs, 
Wyoming HSA.
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Early-Stage Prostate Cancer: Screening and Treatment
Prostate cancer is an age-related condition that occurs more commonly as men 
get older. Most prostate cancer is slow growing and often never causes problems 
or becomes life threatening. However, if prostate cancer does spread outside the 
prostate, it can cause bone pain and death. One complication in knowing how best 
to deal with prostate cancer is that there are no perfect tools for distinguishing 
which early-stage prostate cancers will become problematic from those that will 
not. Not all men wish to be screened for prostate cancer (screening means testing 
for the presence of cancer before it causes symptoms), and it is important for men 
to understand the trade-offs involved in the decision.
Screening for cancer with the prostate-specific antigen 
(PSA) test
The PSA test is a blood test that detects the prostate-specific antigen, a protein 
made by the prostate. A high level of PSA in the blood can indicate the presence of 
a cancer. However prostate cancer is not the only thing that can cause the level of 
PSA to be high. This means that sometimes the test leads to a false positive, a high 
reading when there is no cancer in the prostate. In other cases, the PSA test can 
miss a cancer. This is called a false negative.
A second important problem with relying on PSA level for cancer diagnosis is 
that the majority of early-stage prostate cancers are slow growing and unlikely to 
ever become life threatening. Diagnosing these cancers means that the test has 
uncovered the presence of something that does not require treatment. The problem 
is our current inability to distinguish between those early-stage prostate cancers 
that will grow slowly and those that will develop into aggressive disease.
How prostate cancer is diagnosed and treated
If the level of PSA is elevated, a biopsy is needed to determine whether cancer is 
present. A prostate biopsy can be painful, and there is a small risk of infection and 
bleeding. If cancerous cells are present in the biopsy, the clinician and the patient 
need to decide whether to engage in immediate active treatment and, if so, what 
type of treatment. There is often considerable uncertainty as to whether the cancer 
cells will ever grow enough to harm the patient.
There are three categories of treatment for early-stage prostate cancer: active 
surveillance, surgery and radiation. Active surveillance, also known as “expectant 
management,” involves regularly monitoring the cancer and deciding on treatment 
only if it shows signs of progressing. Surgery to treat prostate cancer, known as a 
prostatectomy, removes the entire prostate gland. Radiation therapy is intended to 
kill the prostate cancer cells. For men who choose radiation therapy to treat their 
prostate cancer, several types are available.
Each treatment choice has both benefits and drawbacks. The benefit of choosing 
active surveillance is avoiding the side effects of surgery and radiation. But men 
who choose active surveillance risk having their cancers grow to the point that they 
Early-Stage
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begin to cause symptoms, including pain, or become life threatening. Surgery may 
reduce a man’s chances of dying from prostate cancer. But for many men, especially 
those with other health issues, the prostate cancer will never cause harm, even if 
left untreated. In addition, if the cancer has spread beyond the prostate, removing 
it surgically may not offer a cure.
Like any major surgery, removing the prostate gland poses risks. The most serious 
of these include death, heart attack, stroke, pneumonia and a blood clot in the 
lungs. Far more common side effects are urine leakage (incontinence) and sexual 
problems (erectile dysfunction). About a third of men who undergo prostate surgery 
suffer incontinence and half suffer from erectile dysfunction. Radiation has many 
of the same common side effects as surgery and, in addition, can cause damage 
to the bowel and rectum. It is not known to what extent, if any, radiation treatment 
reduces the risk of dying of early-stage prostate cancer.
Patient choices
The first choice men face is whether or not to have a PSA test. Many clinicians 
begin recommending the test when a man reaches the age of 50. For men at 
increased risk of prostate cancer, including those with a family history of prostate 
cancer and African American men, some guidelines recommend prostate cancer 
screening at the age of 40. Recent studies have found that getting a PSA test might 
offer a small reduction in the risk of death from prostate cancer in men who start 
screening between the ages of 55 and 69.18 For older men, however, especially 
those over age 75, catching prostate cancer early and treating it probably will not 
reduce the risk of dying from prostate cancer. The uncertainty about whether and 
whom to screen is reflected in the more than tenfold variation in rates of PSA 
testing among men age 68-74 (Map 10).
One thing for men to keep in mind is that prostate cancer treatments themselves can 
cause lasting problems or even death. This is an especially important consideration 
in light of the fact that many prostate cancers will not progress or cause symptoms 
within a man’s lifetime. For men who would want to have treatment if cancer is 
found, the choice to have the PSA test will give them the opportunity to find and 
treat prostate cancer before it causes symptoms. Another way to think about this is 
the test may be right for men who worry more about the possible harms of cancer 
than about the possible harms of treatment. Other men choose not to have the 
test because they would rather not know about a cancer that may never cause 
problems. These men worry more about the possible harms of treatment than 
about the possible harms of the cancer.
Once early-stage prostate cancer has been diagnosed, a patient then must make 
a decision about how he wants to be treated. Active surveillance avoids the side 
effects of treatment, but men who choose this option run the risk that their cancer 
will progress and eventually cause symptoms or lead to death. This option also 
generally involves regular biopsies. Surgery may reduce the risk of dying of prostate 
cancer, but it has significant side effects. It is not clear that radiation reduces the 
risk of death for men diagnosed with early-stage prostate cancer, and it too has 
Early-Stage
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side effects. The differences in prostate cancer treatment across the country are 
reflected in the very high variation in rates of prostatectomy surgery during 2003-07 
(Map 11).
The decision about whether or not to undergo PSA screening should be shared 
between a clinician and a fully informed patient. Once an early-stage cancer is 
detected, the well-informed patient may choose to undergo immediate intervention 
to treat the prostate cancer, or he may wish to avoid immediate treatment and 
pursue active surveillance.
Map 10. Percent of male Medicare beneficiaries age 68-74 receiving prostate-specific antigen (PSA) testing among 
hospital referral regions (2008)
The colors on the map represent the percentages of male Medicare beneficiaries age 68-74 having PSA tests in each HRR. Rates 
are adjusted for race. More than 55% of men age 68-74 underwent PSA testing in the Wilmington, North Carolina HRR in 2008, 
more than ten times more than in Minot, North Dakota, where about 5% of men age 68-74 had a PSA test. In the U.S., on average, 
35% of men age 68-74 underwent PSA testing in 2008.
There was high variation in the percentage of men receiving PSA testing among the HSAs that make up the Sacramento, California 
HRR. Less than 5% of men age 68-74 had PSA tests in the Grass Valley HSA, while almost 39% of men—nearly 8 times more—
received PSA testing in Roseville.
Early-Stage
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Map 11. Radical prostatectomy per 1,000 male Medicare beneficiaries among hospital referral regions (2003-07)
The colors on the map represent the rates of surgical removal of the prostate (prostatectomy) per 1,000 male Medicare benefi-
ciaries in each HRR. Rates are adjusted for age and race. Men over 65 enrolled in traditional Medicare living in San Luis Obispo, 
California—where there were 3.8 surgeries per 1,000 during 2003-07—were more than twelve times more likely to undergo radical 
prostatectomy for prostate cancer than men living in Albany, Georgia (0.3 per 1,000). The national average rate of prostatectomy was 
1.4 procedures per 1,000 men.
The greatest variation within a single HRR was seen in Spokane, Washington, where the rate of prostate surgery ranged from 0.6 
per 1,000 male beneficiaries in the Lewiston, Idaho HSA to 4.2 per 1,000 male beneficiaries in the Wenatchee, Washington HSA.
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Ensuring Patients Get the Care They Need and Want
Undergoing surgery is an important event in the life of any patient. So is taking a test, 
such as the PSA test, which can lead to a diagnosis of a disease that may or may 
not matter to the patient’s health. Even the decision to undergo medical treatment 
with drugs involves important choices. Most patients need help to understand the 
trade-offs involved in treatment decisions. Many patients will then want to discuss 
their options with their clinicians and come to a shared decision about the best 
course of action.
For patients: becoming informed
If you are a patient facing a treatment choice or diagnostic decision (for example, 
PSA screening for prostate cancer), your primary care physician is one of the 
best resources to go to for more information. Two major primary care physician 
groups, the American College of Physicians and the American Academy of Family 
Physicians, have endorsed the practice of shared decision-making; so has the 
American Medical Association (AMA). According to a recent AMA statement, 
“although patients always have the right to participate in decisions about their 
medical treatment, using formal shared decision-making processes can be 
especially useful in cases where more than one treatment option is available, and 
no treatment is considered ‘best’ according to clinical evidence.”19
Perhaps the most important aspect of sharing medical decisions is becoming 
fully informed. According to the AMA, one of the best ways for patients to become 
informed is with a “patient decision aid.” A patient decision aid can be a brochure, a 
video or DVD, or a web-based interactive program. These aids are intended to help 
patients understand their condition, what is known about the possible treatments for 
it, and the potential benefits and risks of various treatment decisions. Aids should 
also help patients consider their personal values and how they might weigh their 
various treatment options based on how they feel about different possible outcomes.
Some patient decision aids are available for free on the Internet. They may also be 
provided as a service by your health insurer. Your primary care physician may be 
able to help you find the aid that is best for you, or you can ask your insurer to make 
aids available. Your clinician may also have someone in his or her office—such as 
a nurse or case manager—who can help you with the information in the aid. Once 
you have seen or read the decision aid, your physician or another clinician should 
be able to discuss your options with you and share important decisions about how 
you want to be treated, including many treatments that may be delivered by another 
physician, such as a surgeon.
If you have a condition that can be treated with either an elective surgery or a less 
invasive option, or if you are considering a screening test such as a PSA test, 
you may also want to know how likely it is that people in your area are receiving 
one treatment or another. This report provides information about your chances of 
undergoing one of the ten surgeries and the test detailed in the previous section, 
depending upon where you live. If your clinician has recommended back or knee 
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surgery, for example, you can find out the rate of each procedure in your community 
and compare that to the rate in other communities near you and in the rest of the 
U.S. Rates for all HRRs and HSAs are available at the Dartmouth Atlas web site 
(www.dartmouthatlas.org).
For example, the map below shows the rates of cardiac bypass surgery in the 121 
hospital service areas within Minnesota. A hospital service area includes at most a 
handful of hospitals and may not include a referral hospital where cardiac bypass 
surgery is performed; patients may need to travel to a larger tertiary care hospital 
in another HSA within the HRR to have this procedure. The rates of cardiac bypass 
surgery given for each HSA reflect people’s chances of undergoing that procedure 
if they live in the HSA, regardless of where the surgery was actually performed. In 
Minnesota, the average rate of bypass surgery among Medicare patients living in 
the Breckenridge HSA was 6.9 per 1,000 Medicare beneficiaries in 2003-07. The 
rate of bypass surgery was much lower in Alexandria (2.6 per 1,000) and close to the 
national average in Winona (4.6 per 1,000). This map provides only one example; to 
find the rates in your community for the ten procedures and the test detailed in this 
report, please see the Appendix Table or the Dartmouth Atlas web site.
Map 12. Coronary artery bypass surgery (CABG) per 1,000 Medicare beneficiaries among hospital services areas in 
Minnesota (2003-07)
The colors on the map represent different rates of cardiac bypass surgery (CABG) per 1,000 Medicare beneficiaries in each of the 
121 HSAs in the state of Minnesota. Rates are adjusted for age, sex and race. The highest rate, 6.9 surgeries per 1,000 Medicare 
beneficiaries, was seen in Breckenridge; the lowest rate, 2.0 surgeries per 1,000, was seen in Sleepy Eye. Some HSAs are not 
shown for one of two reasons: either there were not enough CABG procedures performed on beneficiaries living in the region during 
the study period to ensure patient confidentiality; or the population of beneficiaries was not large enough to produce a statistically 
significant rate for this measure. HSAs from other states are shown if their boundaries extend to encompass a significant number 
of beneficiaries living in Minnesota.
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For clinicians: establishing an ethical standard of fully 
informing patients and engaging them in shared decision-
making
The endorsement of shared decision-making and patient decision aids by major 
professional societies represents a significant shift in the concept of informed 
consent. Research has shown that the quality of medical decisions resulting from 
the usual process of informed consent is inadequate. Patients have unrealistic 
expectations of treatment benefits and harms, and clinicians are often poor judges 
of patients’ values. As a consequence, people do not always get the best treatment 
for their condition,4 and we see unwarranted variation in rates of treatment for 
preference-sensitive conditions such as those detailed in this report.1
Medical ethics dictates that patients have the right to understand the possible 
outcomes of their choices. The current ethical standard of informed consent does 
not ensure that patients are adequately informed.20 Patient decision aids represent 
important tools for ensuring fully informed patients, and shared decision-making 
is essential to this process. According to the AMA statement, decision aids have 
three core elements: clinical information, “values clarification,” and guidance to help 
patients make and communicate their treatment decisions. “The clinical information 
should reinforce what a patient has already learned from his or her physician, 
and give the patient the opportunity to consider the information in a different way, 
without being influenced by conscious or unconscious biases on the part of the 
physician.”19 Patient decision aids should also help patients examine their medical 
choices in light of their values. Many elective treatments and tests have important 
social and emotional effects, which patients may not be aware of, and clinicians 
may not take into account when recommending a treatment option.
While some patients may prefer not to participate in shared decision-making, 
research suggests that, compared with patients who receive usual care, patients who 
have access to patient decision aids, and whose physicians and nurses welcome 
and promote shared decision-making, have less conflict about their decisions, and 
make more informed, values-based decisions.4 Clinical studies of patient decision 
aids and shared decision-making have shown an average 20% reduction in rates of 
several operations, depending upon the treatment.4 However, this number reflects 
the average; some patients decide after shared-decision making to change their 
treatment choice from medication or watchful waiting to surgery.
Shared decision-making has important implications for reducing unwarranted vari-
ation in rates of treatment for preference-sensitive conditions. It may be tempting for 
policy makers and clinicians to think that a high rate of any given treatment means 
that patients must be getting all the procedures they need and want. Conversely, 
they might think low rates of surgery represent a shortage of care. But a high rate 
of surgery is no guarantee that the right patients are undergoing surgery—patients 
who are appropriate candidates according to clinical guidelines and who want the 
surgery. By the same token, a low rate of surgery does not necessarily mean that 
patients are avoiding surgery they neither need nor want.16
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For this reason, setting quotas for treatments is not the best approach to reduce 
unwarranted variation. The only way to ensure the rate is “right” is to recognize the 
need for fully informed patients and for clinicians and patients to share treatment 
decisions. For many treatments, including many surgeries and some tests, the right 
rate in a community will probably be lower than the current rate. For other treat-
ments, the right rate may be higher.21
Three crucial steps remain in the process of establishing shared decision-making 
as the ethical standard of care. First, the 2010 Patient Protection and Affordable 
Care Act provides for the development of patient decision aids and for validating 
and disseminating them. Second, physicians and nurses will need to be trained 
in the use of decision aids and the process of sharing decisions. Finally, the legal 
standard of informed consent should be expanded for medical decisions involving 
elective procedures and tests.
Traditional disclosure required for legal informed consent does not lead to well-
informed patients and thus fully informed choices.21 The ethical importance 
of patients making fully informed choices has been recognized by the AMA.19 
States can also promote informed patient choice and shared decision-making by 
acknowledging the benefits of shared decision-making and offering clinicians legal 
protection if a competent patient signs a document affirming he or she has been 
informed and made a shared decision. In 2007, the Washington state legislature 
passed such legislation, and several other states are considering it.22 Shared deci-
sion-making can remedy the omissions of traditional disclosure, promote better 
patient understanding of treatment options, and strengthen the therapeutic alliance 
between clinician and patient.
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Appendix on HRR Variation in 
Minnesota
The distribution graphs in this section provide a simple way 
to show the variation in rates across the 306 hospital referral 
regions. Each dot represents one HRR. The chart summarizes 
two features of the data. The first is a measure of dispersion: if 
the rate per thousand (or whatever measure is on the vertical 
axis) for the highest HRR is two or three times higher than 
the lowest HRR, it suggests substantial variation. Second, the 
distribution graph shows whether the variation is caused by 
just a few outliers—HRRs that, for various reasons, are very 
different from the rest of the country—or whether the variation 
is pervasive and widespread across the country. The 306 
HRRs in the U.S. are represented by blue dots; the red dots 
indicate the five HRRs in Minnesota.
Figure 1. Mastectomy per 1,000 female 
Medicare beneficiaries among hospital 
referral regions (2003-07)
Figure 2. Coronary artery bypass surgery 
(CABG) per 1,000 Medicare beneficiaries 
among hospital referral regions (2003-07)
Figure 3. Percutaneous coronary intervention 
(PCI) per 1,000 Medicare beneficiaries among 
hospital referral regions (2003-07)
M
as
te
ct
om
y 
pe
r 1
,0
00
 fe
m
al
e 
M
ed
ic
ar
e 
be
ne
fic
ia
rie
s
CA
BG
 p
er
 1
,0
00
 M
ed
ic
ar
e 
be
ne
fic
ia
rie
s
PC
I p
er
 1
,0
00
 M
ed
ic
ar
e 
be
ne
fic
ia
rie
s
Duluth 1.9
minneapolis 1.4
Rochester 1.4
st. Paul 1.4
st. Cloud 1.3
Duluth 4.5
Rochester 4.1
minneapolis 3.6
st. Paul 3.3
st. Cloud 2.8
Duluth 14.0
st. Cloud 11.6
minneapolis 10.5
st. Paul 9.9
Rochester 9.1
Embargoed until 12:01am ET, February 24 2011
A REPORT OF THE DARTmOuTH ATlAs PROJECT  37 
2.0
4.0
6.0
8.0
10.0
12.0
14.0
0.0
1.0
2.0
3.0
4.0
5.0
6.0
0.0
1.0
2.0
3.0
4.0
5.0
6.0
7.0
1.0
2.0
3.0
4.0
5.0
6.0
7.0
8.0
9.0
10.0
11.0
Figure 5. Total knee replacement per 1,000 
Medicare beneficiaries among hospital 
referral regions (2003-07)
Figure 6. Total hip replacement per 1,000 
Medicare beneficiaries among hospital 
referral regions (2003-07)
Figure 7. Carotid endarterectomy per 1,000 
Medicare beneficiaries among hospital 
referral regions (2003-07)
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Figure 4. Back surgery per 1,000 Medicare 
beneficiaries among hospital referral 
regions (2003-07)
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Figure 11. Radical prostatectomy per 1,000 
male Medicare beneficiaries among hospital 
referral regions (2003-07)
Figure 8. Cholecystectomy per 1,000 
Medicare beneficiaries among hospital 
referral regions (2003-07)
Figure 9. Transurethral resection of the 
prostate (TURP) for benign prostatic 
hyperplasia (BPH) per 1,000 male Medicare 
beneficiaries 
among hospital 
referral regions 
(2003-07)
Figure 10. Percent of male Medicare 
beneficiaries age 68-74 receiving prostate-
specific antigen (PSA) testing among 
hospital referral 
regions (2008)
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Appendix Table: Rates of common surgical procedures (2003-07) and PSA testing (2008) among Medicare beneficiaries in 
Minnesota hospital service areas
All rates are adjusted for age, race and sex (when appropriate). Surgical rates are expressed as rates per 1,000 Medicare beneficiaries and are averages for the five-year period from 2003 to 2007. Only 
surgical procedures performed during a hospital admission are included. Rates for mastectomy and prostate surgery are sex-specific. PSA testing rates are expressed as the percent of male beneficiaries 
age 68-74 who received a test during 2008. They are adjusted for race only. Data exclude Medicare beneficiaries who were members of risk-bearing health maintenance organizations.
For surgical procedures, hospital service areas with fewer than 26 expected cases are shown in parentheses in the table. All rates for HSAs with 10 or fewer cases during the study period are omitted.
Specific codes used to define the numerators for rates, and methods of age, sex and race adjustment, are included in the Appendix on Methods.
CABG = coronary artery bypass grafting; PCI = percutaneous coronary intervention; TURP for BPH = transurethral resection of the prostate for benign prostatic hyperplasia; PSA = prostate-specific antigen
HSA name Medicare 
beneficiaries 
(2003-07)
Mastectomy 
per 1,000 
female 
Medicare 
beneficiaries 
(2003-07)
CABG 
per 1,000 
Medicare 
beneficiaries 
(2003-07)
PCI per 1,000 
Medicare 
beneficiaries 
(2003-07)
Back surgery 
per 1,000 
Medicare 
beneficiaries 
(2003-07)
Knee 
replacement 
per 1,000 
Medicare 
beneficiaries 
(2003-07)
Hip 
replacement 
per 1,000 
Medicare 
beneficiaries 
(2003-07)
Carotid 
endarterectomy 
per 1,000 
Medicare 
beneficiaries 
(2003-07)
Cholecystectomy 
per 1,000 
Medicare 
beneficiaries 
(2003-07)
TURP for 
BPH per 
1,000 male 
Medicare 
beneficiaries 
(2003-07)
Percent 
of male 
Medicare 
beneficiaries 
age 68-74 
receiving PSA 
test (2008)
Radical 
prostatectomy 
per 1,000 male 
Medicare 
beneficiaries 
(2003-07)
Ada 2,273 (7.7) (8.8) (12.6) (7.9) (7.6)
Aitkin 13,811 3.7 11.6 5.8 10.5 5.5 2.1 1.9 4.1 (2.4)
Albert Lea 34,534 (1.5) 4.0 7.1 4.3 10.8 5.0 1.6 3.2 5.6 20.4 (3.1)
Alexandria 33,736 (0.9) 2.6 11.0 6.5 11.7 5.4 1.5 5.6 5.1 36.6 (2.4)
Appleton 2,924 10.7 (3.8) (7.9) (5.7) (5.0)
Arlington 6,809 2.2 9.2 2.5 12.7 (4.6) 3.0 
Aurora 6,253 4.5 15.6 4.6 11.2 (4.1) (2.1) (2.7)
Austin 26,322 (0.8) 3.9 8.4 2.1 10.6 4.2 1.2 2.9 6.6 
Bagley 5,321 (4.3) 9.6 (2.5) 7.9 (5.6) (3.3) (3.2) (6.7)
Baudette 4,359 (4.4) 19.9 (4.5) 12.3 (6.4) (4.1) (3.4) (6.8)
Bemidji 28,361 (2.5) 5.2 9.6 3.7 9.6 5.3 2.1 5.2 11.6 55.3 (2.0)
Benson 5,545 (2.6) 12.6 (5.5) 12.0 (4.4) (3.3) (4.2)
Bigfork 3,691 (4.1) 14.3 (4.8) 8.4 (8.2) (7.0)
Blue Earth 10,118 3.9 11.0 3.8 8.8 6.2 1.9 2.9 
Brainerd 51,668 0.9 3.4 12.0 6.8 11.4 5.1 1.6 3.8 6.2 36.7 3.1 
Breckenridge 16,331 (1.5) 6.9 7.2 4.2 11.5 5.2 3.5 5.7 6.6 49.8 
Buffalo 15,442 4.0 13.5 6.0 10.2 6.0 2.5 3.2 2.8 24.4 (4.9)
Burnsville 51,025 1.4 3.0 9.2 4.5 11.1 5.1 2.2 3.2 3.7 41.6 2.2 
Cambridge 16,913 (1.3) 3.7 11.0 4.5 9.1 4.2 2.9 3.2 2.8 (2.1)
Canby 4,058 (5.3) 12.7 (5.0) 9.4 (5.0) (5.9)
Cannon Falls 5,865 4.7 12.5 4.9 10.5 (4.8) (2.6) (3.7) (5.0)
Chisago City 14,219 4.4 10.3 7.2 11.1 4.7 2.2 3.3 2.5 (3.1)
Cloquet 13,298 (2.3) 4.0 14.4 3.9 10.7 4.6 1.6 6.5 (5.2) 34.0 (2.7)
Cook 3,989 (5.4) 14.3 (4.9) 10.8 (2.7) (3.5)
Crookston 12,072 5.6 22.0 3.6 9.2 5.4 2.1 3.2 (2.8)
Crosby 10,769 (2.4) 4.5 10.1 5.3 10.5 5.5 1.8 2.9 (5.4) 47.0 (2.9)
Dawson 2,419 (8.5) (4.7) (8.7) (5.1)
Deer River 6,353 3.2 19.1 4.1 11.9 (3.2) (2.5) (6.2)
Detroit Lakes 22,571 (1.4) 6.8 8.8 4.9 11.2 5.2 3.0 5.8 4.3 58.3 (2.1)
Duluth 120,878 1.7 4.4 14.4 4.9 11.1 4.8 1.9 5.1 5.5 24.1 1.6 
Elbow Lake 2,767 7.4 (4.8) (10.3) (6.8) (4.2)
Ely 6,046 3.7 13.3 (5.3) 12.7 (6.1) (4.4) (4.0)
Fairmont 20,170 (1.8) 3.3 8.6 6.3 9.9 6.5 1.6 2.6 1.6 (2.8)
Faribault 23,071 (1.4) 3.3 10.9 3.8 9.6 4.1 1.8 3.5 3.7 24.9 (2.5)
Farmington 5,679 2.9 8.3 (4.2) 10.5 (3.8) (2.6) (5.2) (7.6)
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HSA name Medicare 
beneficiaries 
(2003-07)
Mastectomy 
per 1,000 
female 
Medicare 
beneficiaries 
(2003-07)
CABG 
per 1,000 
Medicare 
beneficiaries 
(2003-07)
PCI per 1,000 
Medicare 
beneficiaries 
(2003-07)
Back surgery 
per 1,000 
Medicare 
beneficiaries 
(2003-07)
Knee 
replacement 
per 1,000 
Medicare 
beneficiaries 
(2003-07)
Hip 
replacement 
per 1,000 
Medicare 
beneficiaries 
(2003-07)
Carotid 
endarterectomy 
per 1,000 
Medicare 
beneficiaries 
(2003-07)
Cholecystectomy 
per 1,000 
Medicare 
beneficiaries 
(2003-07)
TURP for 
BPH per 
1,000 male 
Medicare 
beneficiaries 
(2003-07)
Percent 
of male 
Medicare 
beneficiaries 
age 68-74 
receiving PSA 
test (2008)
Radical 
prostatectomy 
per 1,000 male 
Medicare 
beneficiaries 
(2003-07)
Fergus Falls 27,162 (1.9) 4.5 7.4 3.6 11.1 5.1 2.5 5.9 4.4 46.7 (1.1)
Forest Lake 8,386 3.9 12.4 6.6 11.2 6.3 (1.7) 2.9 
Fosston 4,742 (3.8) 10.3 (6.0) 10.7 (3.7) (5.1) (5.0)
Glencoe 9,646 2.9 11.8 3.9 12.6 4.6 (1.3) 5.6 (3.5)
Glenwood 7,198 3.1 9.5 4.5 11.6 (5.7) (2.5) 7.1 
Graceville 1,961 (5.4) (10.8) (6.6) (10.7)
Grand Marais 3,616 (2.9) 17.5 (2.9) 16.7 (6.5) (8.8)
Grand Rapids 24,285 (1.8) 3.8 13.7 4.4 10.4 4.7 2.0 4.0 7.4 (2.2)
Granite Falls 8,201 (2.8) 2.6 6.8 6.3 12.0 5.3 (2.1) 4.6 (3.7)
Hallock 2,439 (6.7) (15.1) (7.4)
Hastings 17,545 (1.1) 3.2 10.1 6.5 11.7 4.9 1.6 3.8 9.0 (2.0)
Hendricks 2,272 (5.2) (6.9) (12.4) (9.1) (5.1)
Hibbing 23,546 (1.4) 4.6 16.0 4.4 10.0 5.2 1.9 3.0 6.4 
Hutchinson 17,029 (1.5) 3.3 12.5 4.7 13.4 5.1 1.5 5.6 2.5 43.6 (2.2)
International Falls 10,457 3.7 11.2 4.1 11.7 4.9 2.8 3.1 (4.7) 52.0 
Ivanhoe 1,229 (9.1) (17.0)
Jackson 4,526 (3.3) 11.1 (3.8) 9.4 (7.8) (2.5)
Karlstad 1,724 (10.6) (6.4) (11.7) (6.8)
Lake City 6,076 4.3 7.0 3.6 10.3 (4.6) (2.7)
Lakefield 2,877 (5.3) 11.5 (10.3) (5.4) (5.0)
Le Sueur 3,891 (3.1) 11.7 (3.9) 11.8 (7.5) (2.8) (7.2)
Litchfield 10,888 (1.8) 3.3 12.3 4.8 12.7 4.2 1.6 5.7 (6.0)
Little Falls 23,101 (1.7) 3.1 12.4 6.8 13.1 5.6 2.5 3.9 2.5 41.1 (3.2)
Long Prairie 5,227 11.3 (5.6) 10.7 (3.5) (4.3)
Luverne 7,107 4.7 12.5 4.7 15.8 (5.1) (2.4) 5.2 (5.4)
Madelia 2,805 (5.3) 13.3 (7.7) (5.5) (5.9)
Madison 3,445 (3.2) 7.1 (6.3) (13.4) (5.2) (3.6)
Mankato 42,065 1.5 3.5 8.3 4.3 11.6 5.5 1.7 4.4 2.0 40.2 (1.6)
Maplewood 52,825 1.4 3.0 9.2 6.6 12.2 4.4 2.3 4.2 4.7 18.5 2.5 
Marshall 11,260 5.0 8.5 4.0 12.4 4.3 2.2 5.1 (4.7) 48.5 
Melrose 4,028 10.3 (5.9) 11.0 (5.3) (3.2) (3.4)
Minneapolis 469,355 1.3 3.4 10.6 5.1 9.8 4.8 2.2 3.2 4.2 27.8 2.6 
Montevideo 9,371 2.5 10.3 2.7 8.0 3.9 (2.1) 6.8 (7.7)
Monticello 9,612 (2.5) 2.7 10.4 6.3 11.8 4.6 (2.0) 3.9 37.8 (4.1)
Moose Lake 7,006 3.7 14.8 5.6 10.6 (6.1) (2.1) 3.2 (6.2) (3.9)
All rates are adjusted for age, race and sex (when appropriate). Surgical rates are expressed as rates per 1,000 Medicare beneficiaries and are averages for the five-year period from 2003 to 2007. Only 
surgical procedures performed during a hospital admission are included. Rates for mastectomy and prostate surgery are sex-specific. PSA testing rates are expressed as the percent of male beneficiaries 
age 68-74 who received a test during 2008. They are adjusted for race only. Data exclude Medicare beneficiaries who were members of risk-bearing health maintenance organizations.
For surgical procedures, hospital service areas with fewer than 26 expected cases are shown in parentheses in the table. All rates for HSAs with 10 or fewer cases during the study period are omitted.
Specific codes used to define the numerators for rates, and methods of age, sex and race adjustment, are included in the Appendix on Methods.
CABG = coronary artery bypass grafting; PCI = percutaneous coronary intervention; TURP for BPH = transurethral resection of the prostate for benign prostatic hyperplasia; PSA = prostate-specific antigen
Appendix Table (continued): Rates of common surgical procedures (2003-07) and PSA testing (2008) among Medicare 
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HSA name Medicare 
beneficiaries 
(2003-07)
Mastectomy 
per 1,000 
female 
Medicare 
beneficiaries 
(2003-07)
CABG 
per 1,000 
Medicare 
beneficiaries 
(2003-07)
PCI per 1,000 
Medicare 
beneficiaries 
(2003-07)
Back surgery 
per 1,000 
Medicare 
beneficiaries 
(2003-07)
Knee 
replacement 
per 1,000 
Medicare 
beneficiaries 
(2003-07)
Hip 
replacement 
per 1,000 
Medicare 
beneficiaries 
(2003-07)
Carotid 
endarterectomy 
per 1,000 
Medicare 
beneficiaries 
(2003-07)
Cholecystectomy 
per 1,000 
Medicare 
beneficiaries 
(2003-07)
TURP for 
BPH per 
1,000 male 
Medicare 
beneficiaries 
(2003-07)
Percent 
of male 
Medicare 
beneficiaries 
age 68-74 
receiving PSA 
test (2008)
Radical 
prostatectomy 
per 1,000 male 
Medicare 
beneficiaries 
(2003-07)
Mora 13,243 (2.7) 3.3 12.1 6.3 10.1 3.5 1.9 3.4 (5.0) (2.5)
Morris 8,868 4.9 12.5 6.3 10.1 6.1 (2.4) 5.6 (5.6)
New Prague 16,896 (1.6) 2.8 11.6 4.8 13.0 5.5 1.6 3.0 5.9 (2.5)
New Ulm 18,517 (1.6) 2.7 10.1 3.4 11.1 4.5 2.1 5.2 1.7 (1.8)
Northfield 13,397 2.6 13.8 4.2 9.6 4.9 1.2 4.8 (8.4) (2.9)
Olivia 7,961 2.9 8.5 5.3 13.9 7.3 3.8 (6.5)
Onamia 7,731 3.9 13.9 4.9 9.9 (5.3) (3.1) 5.1 (3.2) (3.0)
Ortonville 5,360 (3.9) 9.1 (7.5) 9.6 (5.4) (2.4) (4.0)
Owatonna 17,103 (1.8) 3.5 9.1 3.3 14.9 5.3 2.0 2.9 4.1 30.7 (3.5)
Park Rapids 18,477 (2.5) 6.5 10.2 4.4 10.4 4.5 2.4 6.5 5.3 45.3 (2.3)
Paynesville 6,250 3.2 11.7 7.1 10.1 (8.1) (2.1) (2.7)
Perham 7,990 4.8 10.3 3.3 10.1 5.7 (2.4) 5.3 (4.2)
Pipestone 5,741 (4.4) (3.0) 6.9 (5.6) 11.9 (3.5) (6.2)
Princeton 15,814 3.3 12.7 4.7 8.7 4.8 1.9 3.1 4.3 (3.3)
Red Wing 16,333 (2.1) 4.3 10.0 4.0 11.4 5.5 1.1 2.5 2.9 
Redlake 1,225 (9.6) (34.8) (11.2)
Redwood Falls 9,583 (2.7) 3.7 6.9 4.4 9.5 4.6 (1.8) 2.9 (3.3) 54.3 
Robbinsdale 58,598 1.4 3.3 9.7 5.1 10.5 4.1 1.6 2.8 4.1 14.2 2.4 
Rochester 118,269 1.3 3.9 9.8 2.9 9.9 5.1 1.5 3.1 1.6 45.7 2.2 
Roseau 8,185 6.1 16.5 3.9 7.7 4.3 (2.4) 2.5 (6.6)
Rush City 8,544 2.9 10.7 5.6 10.4 4.5 (3.0) 3.4 (2.8)
Sandstone 2,517 (4.6) 16.0 (6.2) (8.2) (6.2)
Sauk Centre 5,773 3.6 12.1 (8.9) 14.6 (4.8) (3.0) (4.5)
Shakopee 26,631 (1.2) 2.9 9.5 4.0 10.4 4.5 2.1 3.5 5.2 26.8 (1.4)
Slayton 5,906 4.9 11.0 (6.3) 12.8 (4.1) (2.4) (2.8)
Sleepy Eye 6,079 2.0 9.8 (4.6) 12.6 (5.5) (4.6)
Springfield 6,576 3.5 10.5 4.5 9.7 (6.4) (1.9) 3.8 
St. Cloud 87,170 1.0 2.8 11.7 7.6 11.4 5.4 2.4 3.8 3.2 50.7 2.9 
St. James 5,153 (2.7) 7.2 8.2 (5.8) (3.0)
St. Louis Park 81,904 0.8 3.0 7.8 5.0 9.6 5.3 1.8 2.8 4.4 17.7 2.0 
St. Paul 240,349 1.3 3.1 10.0 5.1 10.5 4.6 1.9 3.9 5.0 29.0 3.1 
St. Peter 7,962 3.2 8.6 3.1 12.3 6.6 (1.7) 3.8 (3.2)
Staples 6,438 3.5 13.7 5.0 9.9 (3.3) (2.6) 5.7 (3.9)
Starbuck 3,383 (3.1) 9.9 (4.0) 9.3 (6.3) (4.1) (4.3)
Stillwater 19,569 (2.1) 2.9 10.5 6.0 14.3 5.9 1.5 4.2 4.2 (2.7)
All rates are adjusted for age, race and sex (when appropriate). Surgical rates are expressed as rates per 1,000 Medicare beneficiaries and are averages for the five-year period from 2003 to 2007. Only 
surgical procedures performed during a hospital admission are included. Rates for mastectomy and prostate surgery are sex-specific. PSA testing rates are expressed as the percent of male beneficiaries 
age 68-74 who received a test during 2008. They are adjusted for race only. Data exclude Medicare beneficiaries who were members of risk-bearing health maintenance organizations.
For surgical procedures, hospital service areas with fewer than 26 expected cases are shown in parentheses in the table. All rates for HSAs with 10 or fewer cases during the study period are omitted.
Specific codes used to define the numerators for rates, and methods of age, sex and race adjustment, are included in the Appendix on Methods.
CABG = coronary artery bypass grafting; PCI = percutaneous coronary intervention; TURP for BPH = transurethral resection of the prostate for benign prostatic hyperplasia; PSA = prostate-specific antigen
Appendix Table: Rates of common surgical procedures (2003-07) and PSA testing (2008) among Medicare beneficiaries in 
Minnesota hospital service areas
Embargoed until 12:01am ET, February 24 2011
A Report of the Dartmouth Atlas Project
42 ImPROVING PATIENT DECIsION-mAKING IN HEAlTH CARE
HSA name Medicare 
beneficiaries 
(2003-07)
Mastectomy 
per 1,000 
female 
Medicare 
beneficiaries 
(2003-07)
CABG 
per 1,000 
Medicare 
beneficiaries 
(2003-07)
PCI per 1,000 
Medicare 
beneficiaries 
(2003-07)
Back surgery 
per 1,000 
Medicare 
beneficiaries 
(2003-07)
Knee 
replacement 
per 1,000 
Medicare 
beneficiaries 
(2003-07)
Hip 
replacement 
per 1,000 
Medicare 
beneficiaries 
(2003-07)
Carotid 
endarterectomy 
per 1,000 
Medicare 
beneficiaries 
(2003-07)
Cholecystectomy 
per 1,000 
Medicare 
beneficiaries 
(2003-07)
TURP for 
BPH per 
1,000 male 
Medicare 
beneficiaries 
(2003-07)
Percent 
of male 
Medicare 
beneficiaries 
age 68-74 
receiving PSA 
test (2008)
Radical 
prostatectomy 
per 1,000 male 
Medicare 
beneficiaries 
(2003-07)
Thief River Falls 14,055 6.8 15.4 4.0 8.7 4.3 1.8 3.8 5.3 47.3 
Tracy 3,909 (6.7) 14.4 (4.6) 12.9 (5.6) (4.9)
Two Harbors 6,097 2.6 14.5 6.3 14.7 (4.3) (3.5)
Tyler 2,310 (5.2) (5.6) (14.3) (5.5)
Virginia 24,781 (2.3) 4.6 15.5 4.7 12.4 5.1 2.3 4.2 3.9 31.1 
Wabasha 6,628 6.0 6.8 6.1 10.9 (4.3) (1.5) 3.3 
Waconia 35,403 (1.5) 2.8 9.9 5.6 11.9 5.3 1.7 4.5 3.4 19.9 (2.5)
Wadena 12,819 (2.6) 4.7 9.1 6.2 10.1 6.1 1.5 10.3 (3.3) (2.3)
Warren 4,554 (5.2) 30.6 (3.3) 14.0 (6.7) (2.7)
Waseca 7,298 4.4 11.4 3.6 10.3 (4.9) 2.4 
Westbrook 2,294 (8.8) (10.9) (6.0)
Wheaton 4,917 (4.9) 10.8 (4.1) 7.0 (6.0) (2.7) (6.6)
Willmar 32,134 (1.7) 3.1 9.7 5.7 10.4 4.4 2.2 4.1 5.2 45.6 (1.8)
Windom 11,841 3.8 10.1 4.2 10.7 5.3 1.8 2.9 (3.5)
Winona 26,735 (2.2) 4.6 5.5 3.0 7.2 4.2 1.6 3.3 3.6 35.8 (1.2)
Worthington 15,645 (1.7) 3.9 10.5 4.4 10.8 4.8 1.8 3.8 2.8 52.2 (2.0)
All rates are adjusted for age, race and sex (when appropriate). Surgical rates are expressed as rates per 1,000 Medicare beneficiaries and are averages for the five-year period from 2003 to 2007. Only 
surgical procedures performed during a hospital admission are included. Rates for mastectomy and prostate surgery are sex-specific. PSA testing rates are expressed as the percent of male beneficiaries 
age 68-74 who received a test during 2008. They are adjusted for race only. Data exclude Medicare beneficiaries who were members of risk-bearing health maintenance organizations.
For surgical procedures, hospital service areas with fewer than 26 expected cases are shown in parentheses in the table. All rates for HSAs with 10 or fewer cases during the study period are omitted.
Specific codes used to define the numerators for rates, and methods of age, sex and race adjustment, are included in the Appendix on Methods.
CABG = coronary artery bypass grafting; PCI = percutaneous coronary intervention; TURP for BPH = transurethral resection of the prostate for benign prostatic hyperplasia; PSA = prostate-specific antigen
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Appendix on Methods
The methods used in this report were developed over a number of years and have 
been described in detail in peer-reviewed publications and in previous editions of 
the Dartmouth Atlas. The data are drawn from the enrollment and claims data of 
the Medicare program and are restricted to the fee-for-service population over age 
65; HMO patients are not included in our analysis. A brief overview of the approach 
and measures is provided here. For more information, please visit the Dartmouth 
Atlas web site (www.dartmouthatlas.org).
The Geography of Health Care in the United States
Defining hospital service areas
Hospital service areas (HSAs) represent local health care markets for community-
based inpatient care. The definitions of HSAs used in the original edition of the 
Atlas have been retained in subsequent editions in order to provide continuity of the 
market areas. HSAs were originally defined in three steps using 1993 provider files 
and 1992-93 utilization data. First, all acute care hospitals in the 50 states and the 
District of Columbia were identified from the American Hospital Association Annual 
Survey of Hospitals and the Medicare Provider of Services files and assigned to a 
location within a town or city. The list of towns or cities with at least one acute care 
hospital (N=3,953) defined the maximum number of possible HSAs. Second, all 1992 
and 1993 acute care hospitalizations of the Medicare population were analyzed 
according to ZIP code to determine the proportion of residents’ hospital stays that 
occurred in each of the 3,953 candidate HSAs. ZIP codes were initially assigned 
to the HSA where the greatest proportion (plurality) of residents was hospitalized. 
Approximately 500 of the candidate HSAs did not qualify as independent HSAs 
because the plurality of patients living in those cities was hospitalized in other cities.
The third step required visual examination of the ZIP codes used to define each 
HSA. Maps of ZIP code boundaries were made using files obtained from Geographic 
Data Technologies (GDT) (now Tele Atlas) and each HSA’s component ZIP codes 
were examined. In order to achieve contiguity of the component ZIP codes for each 
HSA, “island” ZIP codes were reassigned to the enclosing HSA, and/or HSAs were 
grouped into larger HSAs (see the Appendix on the Geography of Health Care in 
the United States at www.dartmouthatlas.org for an illustration). Certain ZIP codes 
used in the Medicare files were restricted in their use to specific institutions (e.g., a 
nursing home) or a post office. These “point ZIPs” were assigned to their enclosing 
ZIP code based on the ZIP code boundary map.
This process resulted in the identification of 3,436 HSAs. In most HSAs, the 
majority of Medicare hospitalizations occurred in a hospital or hospitals located 
within the HSA.
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Defining hospital referral regions
Hospital referral regions (HRRs) represent health care markets for tertiary medical 
care. As defined in the 1996 Atlas, each HRR contained at least one HSA that 
had a hospital or hospitals that performed major cardiovascular procedures and 
neurosurgery in 1992-93. Three steps were taken to define HRRs.
First, the candidate hospitals and HRRs were identified. A total of 862 hospitals 
performed at least 10 major cardiovascular procedures (DRGs 103-107) on 
Medicare enrollees in both years. These hospitals were located within 458 HSAs, 
thereby defining the maximum number of possible HRRs. Further checks verified 
that all 458 HSAs included at least one hospital performing the specified major 
neurosurgical procedures (DRGs 1-3 and 484).
Second, we calculated in each of the 3,436 HSAs in the United States the proportion 
of major cardiovascular procedures performed in each of the 458 candidate HRRs 
in 1992-93. Each HSA was then assigned provisionally to the candidate HRR 
where most patients went for these services.
Third, HSAs were reassigned or further grouped to achieve (a) geographic 
contiguity, unless major travel routes (e.g., interstate highways) justified separation 
(this occurred in only two cases, the New Haven, Connecticut and Elmira, New York 
HRRs); (b) a minimum population size of 120,000; and (c) a high localization index. 
Because of the large number of hospitals providing cardiovascular services in 
California, several candidate California HRRs met the above criteria but were found 
to perform small numbers of cardiovascular procedures. These HRRs were further 
aggregated according to county boundaries to achieve stability of cardiovascular 
surgery rates within the areas. The process resulted in the definition of 306 hospital 
referral regions.
Surgical Procedure Rates
Surgical procedure rates represent counts of the number of inpatient procedures 
that occurred in a defined time period (the numerator) for a specific population (the 
denominator). The counts of discharges for specific procedures are based on the 
MedPAR files for the measurement years, 2003 to 2007. The denominators are the 
corresponding Medicare enrollee populations that were enrolled in Medicare Part 
A on June 30 of the measurement year. Patients enrolled in risk-bearing HMOs at 
any time during the year (HMO status = A, B or C) are excluded.
The procedure codes used in the MedPAR file are based on the International 
Classification of Disease, ICD-9-CM. Selection of procedure codes is based on 
review of the literature and/or consultation with clinical experts. Some rates are 
suppressed to meet CMS suppression rules for patient confidentiality. Rates with 
fewer than 26 expected events are suppressed because of low statistical precision. 
The specific procedures and the codes used to identify the event in the file are 
given in Table 1.
Surgical Procedure Procedure Code(s) &/or Diagnosis Code(s)
General Surgery
mastectomy for cancer (female) 85.41, 85.43, 85.45, 85.47 174-174.9, excluding 233.0
Cholecystectomy 51.21-51.24 ---
Cardiothoracic Surgery
Coronary artery bypass grafting surgery (CABG) 36.10-36.19 ---
Percutaneous coronary intervention (PCI) 00.66, 36.01-36.02, 36.05, 36.06, 36.07, 36.09 ---
Orthopedic Surgery
Back surgery 
03.0, 03.02, 03.09, 03.6, 80.50-80.54, 
80.59, 81.00-81.09, 81.31-81.39, 81.61-
81.64, 84.60-84.69;
Excluding Dx codes 140-239.9, 324.1, 
630-676, 720.0-720.9, 730-730.99, 
733.1, 733.10, 733.13, 733.8, 733.81-
733.82, 733.95, 805-806.9, 839-839.59, 
E800-E849.9: sx codes 03.2-03.29
03.93, 03.94, 78.50, 78.59, 78.60, 78.69, 
78.90, 78.99, 84.51, 84.52, 84.58, 84.59, 
84.80-84.85
With exclusions above and only with 
Dx codes = 353.9, 355.0, 355.9, 721.0-
721.4, 721.42, 721.7-721.9, 721.90, 
721.91, 722.0, 722.10, 722.11, 722.2, 
722.4, 722.5, 722.51, 722.52, 722.6, 
722.70-722.73, 722.80, 722.81, 722.83, 
722.90-722.93, 723.0, 723.1, 723.8, 
724.00-724.02, 724.09, 724.2-724.6, 
724.70, 724.71, 724.79, 724.8, 724.9, 
737.0, 737.1, 737.10, 737.19, 737.20, 
737.3, 737.30, 737.32, 737.34, 737.39, 
737.43, 737.8, 737.9, 738.4, 756.11, 
756.12, 846.0, 846.1-846.3, 846.8, 846.9, 
847.0, 847.2, 847.9
Hip replacement 81.51 Excluding 820-821.39, 996.4x
Knee replacement 81.54 ---
Vascular Surgery
Carotid endarterectomy 38.12 --- 
Urology
TuRP for BPH (male) 60.2, 60.21, 60.29 Dx slots 1-5 = 600x-601.4, 601.8, 601.9, 602x-602.1, 788.2-788.29, 788.4x
Radical prostatectomy (male) 60.5x ---
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Surgical Procedure Procedure Code(s) &/or Diagnosis Code(s)
General Surgery
mastectomy for cancer (female) 85.41, 85.43, 85.45, 85.47 174-174.9, excluding 233.0
Cholecystectomy 51.21-51.24 ---
Cardiothoracic Surgery
Coronary artery bypass grafting surgery (CABG) 36.10-36.19 ---
Percutaneous coronary intervention (PCI) 00.66, 36.01-36.02, 36.05, 36.06, 36.07, 36.09 ---
Orthopedic Surgery
Back surgery 
03.0, 03.02, 03.09, 03.6, 80.50-80.54, 
80.59, 81.00-81.09, 81.31-81.39, 81.61-
81.64, 84.60-84.69;
Excluding Dx codes 140-239.9, 324.1, 
630-676, 720.0-720.9, 730-730.99, 
733.1, 733.10, 733.13, 733.8, 733.81-
733.82, 733.95, 805-806.9, 839-839.59, 
E800-E849.9: sx codes 03.2-03.29
03.93, 03.94, 78.50, 78.59, 78.60, 78.69, 
78.90, 78.99, 84.51, 84.52, 84.58, 84.59, 
84.80-84.85
With exclusions above and only with 
Dx codes = 353.9, 355.0, 355.9, 721.0-
721.4, 721.42, 721.7-721.9, 721.90, 
721.91, 722.0, 722.10, 722.11, 722.2, 
722.4, 722.5, 722.51, 722.52, 722.6, 
722.70-722.73, 722.80, 722.81, 722.83, 
722.90-722.93, 723.0, 723.1, 723.8, 
724.00-724.02, 724.09, 724.2-724.6, 
724.70, 724.71, 724.79, 724.8, 724.9, 
737.0, 737.1, 737.10, 737.19, 737.20, 
737.3, 737.30, 737.32, 737.34, 737.39, 
737.43, 737.8, 737.9, 738.4, 756.11, 
756.12, 846.0, 846.1-846.3, 846.8, 846.9, 
847.0, 847.2, 847.9
Hip replacement 81.51 Excluding 820-821.39, 996.4x
Knee replacement 81.54 ---
Vascular Surgery
Carotid endarterectomy 38.12 --- 
Urology
TuRP for BPH (male) 60.2, 60.21, 60.29 Dx slots 1-5 = 600x-601.4, 601.8, 601.9, 602x-602.1, 788.2-788.29, 788.4x
Radical prostatectomy (male) 60.5x ---
Table 1. Codes Used to Define Procedures
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Adjustment of Rates
Surgical procedure rates are adjusted using the indirect method for age, sex and 
race using the national Medicare population as the standard. Sex-specific population 
estimates are used for prostate and breast procedures. Although the majority of 
events occurred only once per person during the study period, we include multiple 
events to the same person to allow the rates to reflect total health care utilization.
Calculation of age, sex and race adjusted rates
Medicare procedure rates are adjusted using the indirect method for the following 
strata: sex, race (black, non-black) and age (65-69, 70-74, 75-79, 80-84, 85-99). 
The standard population is the U.S. Medicare population age 65 to 99 with Medicare 
Parts A and B entitlement and no HMO enrollment during the measurement period. 
The expected counts within HSAs are computed using the stratum-specific crude 
rates in the standard population, weighting by the stratum-specific population. 
Observed and expected counts at the HSA level are summed to the HRR level. 
Indirectly standardized rates for HRRs are then computed from observed and 
expected counts. A detailed explanation of indirect adjustment is available from the 
Dartmouth Atlas web site.
PSA Testing Rates
Prostate-specific antigen (PSA) screening was measured in men age 68 to 
74 using the Medicare Carrier and Outpatient files with Common Procedural 
Terminology (CPT) codes G0103 or 84153.23 To capture those who had a PSA test 
for a presumed screening indication, men who had any history of prostate disease 
(prostate cancer, prostate surgery, or diagnosis of elevated PSA in the prior three 
years) or who had symptoms in the three months before a PSA test that might have 
triggered a suspicion of cancer according to diagnostic codes billed on visits and 
hospitalizations were excluded from the PSA measure. This algorithm has been 
previously validated.24 Rates were adjusted for race using the indirect method.
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